You will be provided with a reference and some statements. Please determine whether each statement is 'supported', 'unsupported', or 'unknown' with respect to the reference. Please note:
First, assess whether the reference contains any valid content. If the reference contains no valid information, such as a 'page not found' message, then all statements should be considered 'unknown'.
If the reference is valid, for a given statement: if the facts or data it contains can be found entirely or partially within the reference, it is considered 'supported' (data accepts rounding); if all facts and data in the statement cannot be found in the reference, it is considered 'unsupported'.

You should return the result in a JSON list format, where each item in the list contains the statement's index and the judgment result, for example:
[
    {
        "idx": 1,
        "result": "supported"
    },
    {
        "idx": 2,
        "result": "unsupported"
    }
]

Below are the reference and statements:
<reference>
Exogeneous metal ions as therapeutic agents in cardiovascular disease and their delivery strategies - PMC

Metal ions participate in many metabolic processes in the human body, and their homeostasis is crucial for life. In cardiovascular diseases (CVDs), the equilibriums of metal ions are frequently interrupted, which are related to a variety of ...

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov

A

.gov
website belongs to an official
government organization in the United States.

Secure .gov websites use HTTPS

A
lock
(

) or
https://
means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.

Search

Log in

Dashboard

Publications

Account settings

Log out

Search…

Search NCBI

Primary site navigation

Search

Logged in as:

Dashboard

Publications

Account settings

Log in

Search PMC Full-Text Archive

Search in PMC

Journal List

User Guide

PERMALINK

Copy

As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.

Learn more:

PMC Disclaimer

|

PMC Copyright Notice

Regen Biomater
. 2023 Nov 21;11:rbad103. doi:
10.1093/rb/rbad103

Search in PMC

Search in PubMed

View in NLM Catalog

Add to search

Exogeneous metal ions as therapeutic agents in cardiovascular disease and their delivery strategies

Xiaoqian Hong

Xiaoqian Hong

1

Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China

Find articles by
Xiaoqian Hong

1
,
Geer Tian

Geer Tian

2

Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China

3

Binjiang Institute of Zhejiang University, Hangzhou 310053, China

Find articles by
Geer Tian

2,
3
,
Yang Zhu

Yang Zhu

4

Binjiang Institute of Zhejiang University, Hangzhou 310053, China

5

MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China

Find articles by
Yang Zhu

4,
5
,
Tanchen Ren

Tanchen Ren

6

Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China

Find articles by
Tanchen Ren

6,
✉

Author information

Article notes

Copyright and License information

1

Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China

2

Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China

3

Binjiang Institute of Zhejiang University, Hangzhou 310053, China

4

Binjiang Institute of Zhejiang University, Hangzhou 310053, China

5

MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China

6

Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China

✉
Correspondence address. E-mail:
rentanchen120@zju.edu.cn
(T.R.)

Received 2023 Aug 15; Revised 2023 Oct 26; Accepted 2023 Nov 11; Collection date 2024.

© The Author(s) 2023. Published by Oxford University Press.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
https://creativecommons.org/licenses/by/4.0/
), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

PMCID: PMC10761210 PMID:
38173776

Abstract

Metal ions participate in many metabolic processes in the human body, and their homeostasis is crucial for life. In cardiovascular diseases (CVDs), the equilibriums of metal ions are frequently interrupted, which are related to a variety of disturbances of physiological processes leading to abnormal cardiac functions. Exogenous supplement of metal ions has the potential to work as therapeutic strategies for the treatment of CVDs. Compared with other therapeutic drugs, metal ions possess broad availability, good stability and safety and diverse drug delivery strategies. The delivery strategies of metal ions are important to exert their therapeutic effects and reduce the potential toxic side effects for cardiovascular applications, which are also receiving increasing attention. Controllable local delivery strategies for metal ions based on various biomaterials are constantly being designed. In this review, we comprehensively summarized the positive roles of metal ions in the treatment of CVDs from three aspects: protecting cells from oxidative stress, inducing angiogenesis, and adjusting the functions of ion channels. In addition, we introduced the transferability of metal ions in vascular reconstruction and cardiac tissue repair, as well as the currently available engineered strategies for the precise delivery of metal ions, such as integrated with nanoparticles, hydrogels and scaffolds.

Keywords:
metal ions, cardiovascular disease, tissue engineering, oxidative stress, angiogenesis, ion channel
Graphical abstract

Open in a new tab
Introduction

Life activity is the total result of many biologically active substances participating in various chemical reactions, of which metal ions are important parts [
1
]. Metal ions widely exist in nature. As important parts of all kinds of life forms, they participate in almost all basic biological processes and are crucial to the maintenance of human body’s homeostasis. Effective catalysts formed by metal ions are deeply involved in metabolic reactions [
2
]. A considerable number of enzymes need metal ions to maintain catalytic activity [
3
]. Studies have found that more than 50% of modern metabolic pathways depend on metal ions [
4
]. Take metal ions Mn
2+
and Zn
2+
for example, they are important cofactors of many Golgi resident glycosylases. Their homeostasis is necessary for the normal function and stress response of Golgi [
5
]. Owing to their important roles in tissue homeostasis, exogenous metal ions have the potential to work as therapeutic agents in tissue healing and regeneration. The employment of metal ions in bone tissue engineering has gained increasing attentions [
6
]; however, their applications in cardiovascular disease (CVD) therapy have remained largely unexplored.

Of the noncommunicable diseases, CVDs, including ischemic heart disease (IHD), stroke, hypertensive heart disease, cardiomyopathy, rheumatic heart disease and atrial fibrillation are now the leading cause of mortality and morbidity worldwide [
7
,
8
]. Strategies aimed at the pathogenesis have been developed to ameliorate the process of CVDs [
9
]. Taking IHD as an example, after myocardial ischemia occurs, the blood and oxygen supply of the heart are insufficient, leading to abnormal metabolism and excessive production of reactive oxygen species (ROS), accompanied with a large number of cell death [
10
]. The cellular states of cardiomyocytes are directly related with electrical signal conduction and the activity of ion channel, which are essential for rhythmic contraction of the heart [
11
]. Protecting cells from the excessive ROS and inflammatory factors [
12
]; encouraging oxygen and blood vessel restoration [
13
] and correcting rhythmic contraction functions [
14
] have gained momentum to ameliorate the disease progression.

Interventional therapy based on medical devices can treat cardiovascular system with focus delivery is the life-saving straw for many types of CVDs. Therapeutic agents such as small molecule drugs [
15
], stem cells [
16
,
17
] and their derivatives [
18
], extracellular matrix [
19
] and growth factors [
20
] delivered by engineered strategies have shown promising curative effects on CVDs. Among these extrinsic biological active factors, the above-mentioned metal ions possess unique advantages, such as low cost, high stability and safety and diverse drug delivery strategies.

Here, we provide a brief review specifically on the positive effects of metal ions in the treatment of CVDs from three aspects: (i) protecting cells from oxidative stress, (ii) inducing angiogenesis and (iii) adjusting the effects of ion channels. Moreover, we further discuss the engineering strategies for metal ion delivery which can be used in the treatment of CVDs (
Figure 1
).

Figure 1.

Open in a new tab

Metal ions treat CVDs through the following mechanisms. (
A
) the antioxid ant mechanism of metal ions. (
B
) The mechanism of promoting angiogenesis by metal ions. (
C
) Metal ions can participate in regulating ion channels.
Positive effects of metallic ions on cardiac vascular disease

Protecting cells from oxidative stress

Oxidative stress, due to excessive generation of ROS and weak antioxidative defense systems, has been recognized as a molecular trigger of CVDs [
12
,
21
]. In the acute setting of myocardial infarction (MI), excessive ROS generated by abnormal metastasis can significantly lead to mitochondria damage which further lead to cardiomyocyte apoptosis and following inflammatory response [
22
]. In addition, mitochondrial ROS are also closely related to the development of atherosclerotic plaques. Removal of ROS [
23
] and inhibition of ROS related genes [
24
] have been shown to improve myocardial viability, alleviate ischemic injury and the development of atherosclerosis [
25
]. Taking oxidant stress as the target and reducing ROS production may be an effective treatment strategy for various CVDs [
26
].

Many metal ions have antioxidant effects both
in vivo
and
in vitro
. Magnesium (Mg) ion is the basic element of mitochondrial function and plays an important role in cell respiration [
27
]. Mg
2+
have mild antioxidant properties. Dietary Mg intakes can directly affect the level of oxidative stress in the body, accompanied by changes in inflammatory markers and pro-inflammatory molecules, and affected the resulting myocardial tolerance to ischemia-reperfusion stress [
28
,
29
]. Moderate Mg supplementation has been proven to have a significant effect on protecting DNA from oxidative damage [
30
]. Liu
et al.
found that Mg
2+
can be used as a mitochondrial antioxidant to reverse type 2 diabetes-related diastolic dysfunction by increasing ATP, reducing mitochondrial ROS and Ca
2+
overload and ameliorating oxidative stress [
31
].

As an essential trace element of the human body, strontium (Sr) can increase the activity of catalase (CAT) and superoxide dismutase (SOD). In the microenvironment of high-level oxidative stress, a certain concentration of Sr
2+
significantly improved the antioxidant stress capacity of many cells, including leukemia cells of mouse mononuclear macrophage (RAW) [
32
], which is beneficial for maintaining cellular homeostasis after tissue damage. In addition, Sr-SLA, a dental implant material doped with Sr developed by Zhou
et al.
, can significantly promote bone formation by reducing the level of ROS and increasing the content of glutathione peroxidase (GSH) [
33
].

Manganese (Mn) ion can also improve the ROS scavenging ability of implants [
34
,
35
]. The Keap1-Nrf2 signaling pathway plays a core role in mediating the adaptive stress response of cells to oxidants [
36
,
37
]. Mn
2+
can activate the Keap1-Nrf2 pathway as the main antioxidant defense mechanism by upregulating the expression of Nrf2 and promoting its nuclear translocation. At the same time, Mn
2+
can also inhibit the expression of the endogenous inhibitor Keap1 of Nrf2, increase the antioxidant enzymes CAT and superoxide dismutase 2(SOD2), thereby clearing ROS, inhibiting the activity of osteoclast and regulating cell differentiation.

Zinc (Zn) ion, as a bivalent cation, has no redox activity under physiological conditions but has an activation effect on antioxidant proteins and enzymes [
38
]. Therefore, Zn
2+
can be used as an antioxidant to regulate the level of cellular oxidative stress [
39
,
40
]. The relationship between Zn
2+
and oxidative stress has been studied in cell experiments [
41
,
42
], animal experiments [
43
] and clinical trials [
44
].
In vitro
experiments showed, Zn deficiency increased ROS production in hepatic stellate cells and 3T3 cells [
45
,
46
]. In rodent animal experiments, dietary Zn deficiency also showed an increase in oxidative stress levels of vascular smooth muscle cells
in vivo
[
43
,
47
]. The clinical trial showed that compared with the young subjects, the elderly subjects themselves maintained a low plasma Zn
2+
level, and after artificial Zn
2+
supplementation, their plasma lipid peroxidation index significantly decreased [
44
]. This suggests that the increase of plasma Zn concentration may prevent atherosclerosis through antioxidant stress.

Copper (Cu) is a cofactor of superoxide dismutase 1 (SOD1), which catalyzes the disproportionation of superoxide anion to hydrogen peroxide and oxygen [
48
]. Although Cu
2+
cannot directly enhance ROS clearance, studies have shown that a certain concentration of Cu
2+
release can promote the overall enhancement of the intracellular antioxidant system by upregulating SOD1 and promoting M2 polarization in macrophages [
49
]. Studies have shown that abnormal copper homeostasis and copper death are closely related to the occurrence and development of CVDs [
50
].

As the basic elements of many oxidoreductase and complex in mitochondrial respiration, metal ions such as Mg
2+
help to reduce ROS induced inflammatory and adverse tissue remodeling, while other metal ions such as Mn
2+
and Zn
2+
also exhibit certain antioxidant stress effects. Supplementation of the abovementioned metal ions may have beneficial effects on corresponding CVDs.
Inducing angiogenesis

In biological systems, the transfer of nutrients and wastes in cells and tissues is accomplished through functional vascular networks. Therefore, the maintenance of the vascular system is essential to the health of organisms. During MI, long-term ischemia causes abnormal cardiac metabolism, results in a decrease in cardiac contractile function and ejection capacity, ultimately leads to heart failure [
51
]. Angiogenesis can increase the blood supply which improves the local oxygen, nutrition, growth factors and cytokine supply of injured tissues [
52
]. The delivery of therapeutic substances to the ischemic tissue site is an important strategy to promote angiogenesis. For example, growth factors and cytokines [
53
], relevant cells [
54
] and their secretome products [
55
] have been locally or systemically administrated to promote vessel formations in ischemic tissues [
56
]. Many metal ions are considered to be promising as the supplement to treat ischemic diseases because of their role in promoting angiogenesis.

Cu is an essential cofactor in organisms [
57
], the lack of Cu can cause deterioration of the tissue function, a recent study involving mice revealed that the Cu level in ischemic heart decreased significantly with the time of MI [
58
]. Cu
2+
has been recognized as an effective angiogenesis stimulator, which affects many processes including endothelial cell proliferation, migration and angiogenesis [
59–61
]. One hypothesis about the angiogenic effect of Cu is mainly through regulating hypoxia-inducible factor-1(HIF-1). Cu participated in multiple steps of HIF-1 regulating target gene expression, such as vascular endothelial growth factor (VEGF) [
62
,
63
]. Another assumption about Cu
2+
function in pro-angiogenesis is the glutathione peroxidase (GPx)-like function in catalyzing the decomposition of endogenous nitride oxide (NO) donors. NO is the first recognized gas transducer, produced in various biological tissues and an important regulatory factor for key cardiovascular system functions [
64–66
]. Huang and Yang
et al.
utilized Cu
2+
to catalyze endogenous NO production, which improve blood compatibility, promote endothelialization and reduce restenosis of Cu-DOTA (1,4,7,10-Tetraazacyclododecane-
N
,
N
′,
N
″,
N′″
-tetraacetic acid) complex decorated stents [
67–70
]. Besides, Wang
et al.
introduced copper ions into multilayer coatings via the catechol-Cu coordination to simulate the key functions of healthy endothelial cells, which has the potential to be applied for the modification of blood-contacting devices [
71
]. Except for the direct functions on endothelial cells, the research of Wang
et al.
found that the exosomes secreted by macrophages stimulated by Cu
2+
can also upregulate the angiogenesis ability of endothelial cells [
72
].

At present, the specific mechanism of silver nanoparticles (AgNPs) on wound healing still needs to be further explored. Tian
et al.
found that in a heat injury model, AgNPs treatment induced a higher level of transforming growth factor-β expression at the edge of wounds, which further lead to an increase in VEGF mRNA and keratinocytes migration toward wound area. This might contribute to the function of Ag
+
released by AgNPs [
73
].

Mg
2+
have shown angiogenesis promoting effect by increasing the secretion of angiogenic substances such as VEGF, endothelial nitric oxide synthase (eNOS) [
74
] and platelet-derived growth factor-BB (PDGF-BB) [
75
]. Qin
et al.
found that Mg
2+
upregulated the angiogenesis-related genes HIF-1a and eNOS by activating the Notch signaling pathway in bone marrow mesenchymal stem cells, thereby promoting angiogenesis after implantation [
76
]. In addition, Mg
2+
has also been found to promote the formation of new bones and microvessels surrounding implants, which is beneficial for materials-tissue integrations [
77–79
]. Besides, Zhang
et al.
found that a green tea phenol-Mg
2+
induced multilayer conversion coating could enhance the adhesion and proliferation of endothelial cells, and improve the biocompatibility of cardiovascular implants [
80
].

Cobalt (Co) ion is another candidate for angiogenesis stimulation, as it can simulate hypoxia conditions by upregulating HIF-1a, change the expression of hypoxia-related genes involved in angiogenesis and apoptosis, such as VEGF and fibroblast growth factor, stimulate the production of erythropoietin and promote the polarization, migration and homing of endothelial cells [
81
,
82
]. In addition, exosomes secreted by macrophages stimulated by Co
2+
also have the effect to promote angiogenesis [
83
]. Research has shown the potential in using a combination of fluoride and Co
2+
to simultaneously promote osteogenesis and angiogenesis [
84
].

Sr
2+
can also act as an accelerator for vascularization by stimulating neutrophils. Compared with pure gelatin scaffolds, Sr-doped gelatin scaffolds stimulated more N2 polarization of neutrophils, accompanied by greater production of angiogenic factors (such as PDGF-BB, VEGF, and stromal cell-derived factor-1). Sr-doped gelatin scaffolds also increased the switch of macrophages to M2 phenotype, ultimately enhanced tissue regeneration [
85
]. In addition, Mao
et al.
have reported that Sr and Si bioactive ions had synergistic effects on angiogenesis in osteoporotic bone regeneration [
86
].

Lanthanum (La) is a metallic rare earth element. Luo
et al.
used Mg
2+
and La
3+
as biological signal molecules and developed an ion co-delivery system using microspheres as carriers. The results showed that compared with the system that only released Mg
2+
or La
3+
, the combined system had a more significant effect on angiogenesis, thus promoting the regeneration of vascularized bone tissue [
87
]. However, further research is needed to explore whether the role of La
3+
in promoting angiogenesis in cooperation with other metal ions can be applied to the field of CVD treatment.

For most of metal ions the effects in promoting vascularization process are contributed by the upregulated expression of VEGF and other growth factors. Moderate supplementation of the above-mentioned metal ions can have a certain therapeutic effect on the recovery of cardiac function in CVDs characterized by ischemic injury.
Adjusting the effects of ion channels

Ion channels participate in the physiological function and pathophysiological response of cardiovascular system [
88
]. For example, calcium channels contribute to atrioventricular conduction and pacemaker activity [
89
]. In cardiac tissues, K
+
permeable ion channels have the functions of maintaining cell resting potential, regulating cell tension, cell membrane potential, K
+
concentration, cell volume and intracellular signal pathways [
90
]. Given the key roles of ion channels in cardiac conduction and myogenic tension, mutations and dysfunction of these channels can lead to a variety of CVDs and disorders [
91
]. Pathophysiological conditions characterized by hyperactivity of blood vessels, including hypertension and hyperlipidemia, can lead to changes in the expression or function of coronary artery ion channels [
92
,
93
]. Ion channels, in turn, participate in the regulation of heartbeat and coronary artery blood flow [
94–96
]. Metal ions are not only the cargo transporting through ion channels, the presence of metal ion also affect the activity of ion channels in turn, which have attracted widespread attention in the cardiovascular field.

Mg
2+
play an important role in regulating various cation channels in the cardiovascular system. Wang
et al.
found that Mg
2+
supplementation can alleviate pulmonary hypertension by regulating Mg transporters [
97
]. The changes in the concentration of Mg
2+
in myocardial cells or smooth muscle cells may be the basis for altering electrical and mechanical activities of these cells [
98
]. Mg
2+
also regulates other cation channels expressed in cells, mainly potassium and calcium channels, which affect the electrical properties of the myocardium and participate in the pathological and physiological processes of CVDs such as arrhythmia. In addition, Mg
2+
can also regulate myocardial contractility by affecting the intracellular calcium influx [
99
]. In the cardiovascular field, Mg
2+
can affect calcium ion homeostasis, vascular tension, peripheral vascular resistance and cardiac output [
100
].

Zn regulates the activity of multiple ion channels including calcium channel, potassium channel and transient receptor potential channel family of different cell types. Alvarez-Collazo
et al.
studied the effect of extracellular and intracellular Zn
2+
on L-type calcium current (ICaL) and its modulation by β-adrenergic stimulation in rat ventricular myocytes, and found Zn
2+
indeed had a regulating effect on transmembrane calcium movement [
101
]. In addition, Zn
2+
also induced hyperpolarization of smooth muscle cell membrane by inhibiting the voltage-gated calcium channel of smooth muscle, which resulted in vasorelaxation [
102
]. These studies show that Zn
2+
homeostasis may be used as a new target for blood vessel therapy by regulating ion channels.

Metal ions, such as Mg
2+
and Zn
2+
, play important roles in maintaining ion channel functions and expressions, which can exert positive roles in regulating cardiac conduction and vascular tension. The above-mentioned metal ions can become new targets for the treatment of vascular diseases by regulating ion channels.

Other possible mechanisms can also contribute to the cardiovascular protective effects of metal ions, such as regulating pH [
103
], modulating the immune system [
104
], preventing secondary infections in peripheral blood vessels [
105
] and maintaining vascular elasticity [
106
]. The rapid accumulation of lactic acid in ischemic myocardium leads to an acidic microenvironment, where weakly alkaline metal ions such as Mg
2+
and Sr
2+
may consume acid in the environment and regulate local pH values [
107
]. In addition, dietary Mg deficiency and Zn deficiency were found to affect the immune system and accelerate the formation of atherosclerosis by exacerbating chronic inflammatory stress [
108
,
109
]. By supplementing the above-mentioned metal ions for immune regulation, it may be possible to reduce arterial inflammation and improve vascular health. Furthermore, molybdenum (Mo) and Mg
2+
can respectively regulate the plasmalogen and elastic fibers in the vascular wall, which is beneficial for maintaining the elasticity of the arterial wall [
106
,
110
]. For peripheral vascular diseases of diabetes, Cu
2+
, Ag
+
, etc. can prevent the occurrence of local secondary infection in the form of wound dressings [
111
,
112
]. After further research and improvement, the above mechanisms may be utilized for the treatment of CVDs.
Engineering strategies for metallic ion delivery for cardiovascular disease therapy

Although metal ions have various functions, different tissues and physiological and pathological states have different requisition on the types and doses of metal ions for homeostasis maintenance. Excessive metal ion supplementation has non-negligible side effects, such as affecting enzyme activity, altering cell membrane permeability, increasing hepatorenal burden and damaging the immune and reproductive systems [
113
]. Taking Mg
2+
as an example, appropriate local supplementation of Mg
2+
can effectively promote vascularized bone formation. However, excessive Mg
2+
entering the circulatory system will cause hypermagnesemia, inhibit the transmission of nerve muscular system to excitement, and cause adverse consequences [
114
]. Similarly, excessive supplementation of Cu
2+
is toxic and may lead to neurodegeneration [
115
]. Dietary reference intake of some metal ions with potential therapeutic effects on CVDs is listed in
Table 1
[
116
,
117
]. Therefore, engineering methods for on-demand metal ions delivery can increase the ratio between profits and risks (
Figure 2
).

Table 1.

Dietary reference intake of metal ions
a

Metal ion

Children

Adults

RDA/AI

b

UL

RDA/AI

b

UL

Cr (mcg/d)

11–15
b

ND

20–35
b

ND

Cu (mcg/d)

340–440

1000–3000

900

10 000

Mn (mg/d)

1.2–1.5
b

2–3

1.8–2.3

11

Zn (mg/d)

3–5

7–12

8–11

40

Fe (mg/d)

7–10

40

8–18

45

Ca (mg/d)

500–800
b

2500

1000–1200
b

2500

Mg (mg/d)

80–130

65–110

310–420

350

Mo (mcg/d)

17–22

300–600

45

2000

K (g/d)

3.0–3.8
b

ND

4.7
b

ND

V (mg/d)

ND

ND

ND

1.8

Open in a new tab

a
RDA, recommended dietary allowance; AI, adequate intake; UL, upper tolerable level; ND, not determined.

b
These values represent the AI.

Figure 2.

Open in a new tab

Engineering strategies for metal ion delivery.
From nanoparticles and hydrogels to various types of scaffolds and patches [
118
], the application of innovative biomaterials in the field of therapeutic factor delivery has shed new light on the CVD therapy [
119
,
120
]. In order to transfer metal ions that may have therapeutic effects to the diseased regions, researchers have been introduced a variety of carriers [
121
].

Nanoparticles

From a clinical point of view, the system based on nanoparticles is a feasible option to deliver therapeutic drugs to damaged tissues [
122
,
123
]. Nanoparticles can increase targeting and retention of drugs in the desired location of the body, protect unstable molecules from degradation and regulate drug release profile for long-term protection [
124
]. In addition, the targeted organ delivery ability of nanoparticles can minimize the side effects and toxicity to other organs [
125
,
126
]. Nanoparticles also retain the above advantages as carriers of metal ions. Therapeutic metal ion delivered with nanoparticles and their preparation methods are listed in
Table 2
.

Table 2.

Engineering strategies for metal ion delivery based on nanoparticles

Metal ion

Specific biomaterial

Metal ion loading methods

Effects

Zn

LP-loaded ZIF-8 NPs (LP@ZIF-8)

Direct hydrothermal synthesis

Suppress inflammation and regulate lipid metabolism [
131
]

Cu

The γ-polyglutamic acid and Cu-cosynthesized hydroxyapatite (γ-PGA/CuxHAp)

Ion exchange with Ca
2+
in hydroxyapatite

Promote angiogenesis [
134
]

Mn

Ferritin Mn-SOD nanoenzyme (Mito-Fenozyme)

In situ
synthesis of MnO
2
into FTn core via Mn
2+
oxidation

Alleviate oxidative damage [
135
]

Mn

Mn-contained β-tricalcium phosphate (β-TCP) (Mn-TCP) bioceramics

Co-precipitation method

Scavenge ROS via Nrf2 activation [
35
]

Zn

Zinc oxide nanoparticles (ZnO-NPs)

Sol-gel method

Reduce oxidative stress and tissue inflammation [
136
]

Zn

Albumin-based Zn (II)-Quercetin nanoparticles (Que NPs)

Coordination coassembly between bovine serum albumin (BSA) with Quercetin and Zn
2+

Scavenger active oxygens [
137
]

Cu

Cu-deposited cerium oxide nanoparticles (CuCe NPs)

Cu
+
deposition on Ce NPs surface through the mild reduction of Cu
2+
-oleylamine complex.

Promote intracellular antioxidant by upregulating SOD1, promoting M2 polarization of macrophages, increase blood vessel densities [
49
]

Zn

Green synthesized zinc oxide nanoparticles (GS-ZNPs)

Green chemical method using plant extracts as solvents

Inhibit oxidative stress [
138
]

Cu

Artificial hybrid nanosized cells (Hynocell)

In situ
doped Cu nanoclusters into the hollow cavity of FTn

Target ischemic tissues and promote vascular regeneration [
133
]

Zn, Cu

Zn/Cu dual-doped mesoporous silica nanoparticles (ZC-MSN)

Sol-gel method

Inhibit inflammation and promote angiogenesis [
139
]

Open in a new tab
Nanoparticles of metal element or metallic oxide which can decompose
in vivo
are the direct cargoes for metal ions. Created by chemical reduction method or sol-gel method, the size of metal nanoparticles can reach as small as a few nanometers [
127
], which enable them with nanozyme properties in addition to metal supply. Liu
et al.
developed a subminiature copper-based nanoparticles with simulated enzyme properties for the treatment of ROS-related diseases. Cerium dioxide nanoparticles (Ce NPs) have been widely explored as therapeutic nanoenzymes, which have the characteristics of mimicking SOD and CAT. Im Gwang-Bum
et al.
used Ce NPs as an antioxidant carrier, deposited a large amount of Cu
2+
on the surface of Ce NPs through the mild reduction of Cu
2+
oleamine complex and prepared Cu-deposited cerium dioxide nanoparticles (CuCe NPs). As a cofactor of antioxidant enzyme SOD1, Cu can be used in synergistic antioxidant treatment. At the same time, due to its own angiogenic effect, Cu can play a favorable role in the treatment of ischemic vascular disease. Injecting CuCe NPs into the site of MI and local ischemia showed an increase in blood flow perfusion and a reduction in tissue damage [
49
].

Metal organic framework (MOF) is a three-dimensional (3D) network of nanoparticles containing metal ions originally. In addition, formed by the connection of metal centers and organic groups, the micropores of MOFs enable them to be a potential encapsulation shell and drug carrier for many biomedical applications [
128
,
129
]. Zeolite imidazole skeleton 8 (ZIF-8) is a tetrahedral structural unit formed by connecting Zn
2+
with N atoms in methyl imidazole ester, and is one of the most promising representatives in MOF [
130
]. Sheng
et al.
used ZIF-8 as a vehicle to establish a nano losartan potassium (LP)-loaded ZIF-8 drug delivery system. As a zinc-based metal organic skeleton, nanoscale ZIF-8 achieved sustained and stable release of Zn
2+
in vivo
, which synergistically relieved chronic inflammation and regulated lipid metabolism with LP [
131
].

Loading metal ions to nanoparticles composed of protein or other polymers by coordination is another important strategy for preparing metal carrying nanoparticles. Polydopamine (PDA) has abundant metal binding sites on its surface, and researchers have utilized this feature to construct Cu
2+
-loaded PDA to achieve local release of Cu
2+
into the damaged area [
132
]. Ferritin nanocage (FTn) is a type of recombinant protein assembled from 24 ferritin heavy chain subunits, which compose specific sites to bind with polymetallic ions. Utilizing the metal affinity property of FTn, Zhang
et al.
prepared Cu-containing FTn, fused with cell membrane and coated on PLGA nanoparticles integrated with the secretion from hypoxic stem cells to construct artificial hybrid nanocells that promote vascular regeneration of ischemic tissues [
121
].
Hydrogels

Hydrogels, a set of soft materials with large among of water, which have comparable mechanical compliance to native tissues, show unique advantages in tissue engineering [
140
,
141
]. The three-dimensional network structure formed by hydrogels has great capacity in carrying and releasing drugs [
142
,
143
]. When hydrogels are used as the carrier of metal ions, the release profile can be tuned by adjusting the composition, cross-linking degree, pore size, degradation rate and other parameters to meet different treatment requisitions. Therapeutic metal ions delivered by hydrogels and their preparation methods are listed in
Table 3
.

Table 3.

Engineering strategies for metal ion delivery based on hydrogels

Metal ion

Specific biomaterial

Metal ion loading methods

Effects

Mg

GelMA/TCS/POSS-Mg hydrogel

Mg-S bond formed by coordination of Mg and TCS

Promote vascularization both
in vivo
and
in vitro
[
148
]

Zn

Zn
2
SiO
4
-containing composite hydrogel

Coordination between disulfate modified PEG and Zn
2+
after physical disperse Zn
2
SiO
4
powders into HSA pregel solution

Promote angiogenesis and inhibit oxidative damage [
154
]

Ag, Co

Polymerized poly(acrylic acid) (PAA) and branched poly(ethylenimine) (PEI) network of Ag nanoparticles decorated polypyrrole nanotubes (AgPPy) and Co ions (PPCA hydrogel)

Electrostatic interaction between metal ion and PAA and branched PEI network

Promote notable inflammatory reduction and prominent angiogenesis regeneration [
155
]

Ag, Cu

Chitosan (CS)-Ag-Cu hydrogel

Chelation between -NH
2
/-OH and metal ion

Promote cell migration and angiogenesis [
156
]

Mg

MgO/MgCO
3
@poly(lactide-co-glycolide)(PLGA) hydrogel (PMM hydrogel)

Physical disperse MgO and MgCO
3
particles into the prepared PLGA hydrogel

Stimulate cell migration, promote cell adhesion and proliferation [
152
]

Ag

AgNPs-loaded dopamine-grafted hyaluronic acid (HA-DA)/3-aminophenylboronic acid-grafted oxidized methyl cellulose (OMC-PBA) hydrogel

Coordination between dopamine and Ag
+
after disperse AgNPs into the hydrogel precursors

Promote antioxidant stress, antibacterial, cell proliferation, anti-inflammatory and angiogenesis [
157
]

Sr

SrCO
3
/human serum albumin (HSA) composite hydrogel

Coordination between disulfate-modified PEG and Sr
2+
after physical disperse SrCO
3
into pregel solution

Reduce cardiomyocyte apoptosis and increase angiogenesis [
153
]

Mg

GelMA-BP-Mg microspheres

Coordination of metal ion and BP

Promote vascularization [
149
]

Mg

Poly (hydroxypropyl acrylate-co-acrylic acid)-Mg
2+
hydrogel (poly (HPA-co-AA)-Mg
2+
)

Coordination of metal ion and carboxylate

Promote the formation of new blood vessels, the proliferation and migration of fibroblasts and M2 polarization of macrophages [
150
]

Open in a new tab
Based on metal-ligand coordination chemistry, metal ions can directly bind to various chelating ligands coupled on the backbone of hydrogel polymers [
144
,
145
]. The metal ions coordinated in hydrogel network can work as the ionic crosslinker to mold or reinforce the hydrogels. Ligands such as alginates, bisphosphate (BP), catechol, thiolate, which have shown high associate constants to many polyvalent metal ions, have been extensively studied for ion loading. Due to the dynamic property of ionic crosslinking, ion release can be triggered by ion exchange in physiologic environment. The variation of pH, ionic strength, redox state
in vivo
, the present of ions with higher associate constant, the degradation of hydrogel polymer have been utilized to design hydrogels with programable ion release [
146
,
147
]. Zhang
et al.
prepared Mg
2+
-binding double crosslinked hydrogel through the addition of thiolated chitosan (TCS) in gelatin methacryloyl (GelMA) and polyhedral oligomeric silsesquioxane (POSS) photocrosslinked hydrogel. Hydrogel showed sustained release of Mg
2+
for more than 15 days, which promoted angiogenesis
in vitro
and
in vivo
[
148
].

Hydrogel can be prepared into microspheres (microgel) for better shape adaptability and easier minimal invasive introduction. Zhao
et al.
obtained BP grafted GelMA microspheres by microfluidic method and loaded Mg
2+
through coordination between BP and metal ion. GelMA-BP microspheres could be injected by syringe and achieved sustained local release of Mg
2+
to promote local endothelial cell growth [
149
]. Cui
et al.
used the coordination between metal ions and carboxylate to introduce Mg
2+
into the microgel rich in carboxyl groups. Microgel was spread and covered the entire damaged part seamlessly and promote tissue regeneration [
150
].

In addition to introducing metal ions through direct coordination with hydrogel polymer, metal-loaded nanoparticles can also be introduced into hydrogels as an alternative metal ion source [
151
]. By embedding metal nanoparticles in the hydrogel matrix, the release of metal ions could be further stabilized. Moreover, hydrogel with
in situ
gelation property could be used to load metal ion carrying nanoparticles, which further increase the compliance and injectability of the implants. Zhou
et al.
used PLGA/1-methyl-2-pyrrolidinone solution, which is an FDA-approved
in situ
forming implant (ISFI), to load MgO and MgCO
3
particles as alternative Mg
2+
sources. This ISFI could completely fill the irregular defects
in vivo
. As MgO and MgCO
3
had different degradation rates, the sustainable and stable release of Mg
2+
was achieved by adjusting the weight ratio, the two particles doped in the hydrogel [
152
]. Other than the simple physically dispersion, Chang
et al.
used disulfate-modified PEG to coordinate Sr
2+
in SrCO
3
nanoparticles, which also act as a crosslinker for hydrogel. The dynamic binding enabled minimal invasive injection into myocardial tissue of the hydrogel. After I/R, the Sr
2+
-containing hydrogels were injected into murine infarcted myocardium, and the researchers observed the reduction of cardiomyocyte apoptosis and the increase of angiogenesis. This indicates that locally released Sr
2+
has a cardioprotective effect against I/R injury [
153
].
Solid scaffolds

Solid scaffolds with certain mechanical strength are widely used for tissue engineering to support the configuration of injured tissues [
158
]. Scaffolds has been designed into different modality. In the case of CVDs, intravascular stents which can provide support for the arterial wall and ensure blood supply, have become a routine treatment for thrombus [
159
,
160
]. Cardiac patches, which can provide necessary mechanical support for damaged myocardium, have been reported to significantly improve cardiac function [
161
]. Other than mechanical support, scaffolds also provide niches for cell growth and drug reservoirs, metal ions are one of the popular therapeutic factors that used for scaffold designed. We listed the therapeutic metal ion delivered by scaffolds and their preparation methods in
Table 4
.

Table 4.

Engineering strategies for metal ion delivery based on scaffolds

Metal ion

Specific biomaterial

Metal ion loading methods

Effects

Zn, Mg, Cu

Zn-Mg-Cu alloy

Alloy smelting

Augment immunoregulation, angiogenesis, and anti-infective activity [
162
]

Mg

PLGA/oligolactide-grafted Mg(OH)
2
(RA-Mg-OLA) scaffold

Ultrasonic nanocoating method

Reduce inflammatory response [
167
]

Mg, Sr

3D-printed Mg-/Sr-doped Ca silicate scaffold

Blending and sintering

Promote the angiogenesis behavior [
168
]

Zn

Zn-loaded β-tricalcium phosphate/poly(
l
-lactic acid) (TCP/PLLA) scaffold

Wet precipitation and blending

Direct stem cell fate and trigger a pro-healing immune stimul [
169
]

Co

Co-doped Ca
10
Li(PO
4
)
7
(CLP) scaffold

Substitution and sintering

Enhance angiogenic property [
170
]

Ca, Mg

Ca Mg silicate (CMS)/graphene oxide (GO)/silk fibroin (SF) composite scaffold

Chemical precipitation, blending and lyophilization

Upregulate angiogenesis genes and promote angiogenesis of human umbilical vein endothelial cell [
171
]

Mg

Mg-enriched graphene oxide nanoscroll (MgNPs@GNS) deposited decellularized bone matrix scaffold

Electrostatic interactions with GO surface groups and then reduced under solvothermal conditions

Stimulates angiogenesis [
78
]

Sr

Tannic acid (TA)/Sr
2+
-coated silk/graphene oxide-based meniscus scaffold

Coordination with phenolic hydroxyl groups of TA

Eliminate ROS, promote cell migration and facilitate ECM secretion [
172
]

Cu

Catechol-mediated and Cu-incorporated multilayer coating modified SS wires

Catechol-mediated layer-by-layer multilayer coatings via catechol-Cu coordination

Generate NO
in situ
[
71
]

Cu

Epigallocatechin-3-gallate-Cu@rapamycin/bivalirudin-modified PLLA stents (EGCG-Cu@Rapa/BVLD-modified PLLA stents)

Catechol-Cu coordination

Provide sustained NO release, prevent restenosis and promote endothelial healing after stenting [
173
]

Cu

CuII-dopamine (DA)/hexamethylenediamine (HD) coating modified 316 L SS vascular stents

Catechol-Cu coordination

Catalyze NO release, improve the antithrombogenicity, re-endothelialization and further anti-restenosis [
165
]

Cu

Stents grafted/loaded with catechol groups/Cu
2+
films

Catechol-Cu coordination

Catalyze NO release
in situ
[
166
]

Cu

Fibroin/chitosan (SF/CS)/Cu coating modified stents

Metal-protein coordination

Regulate NO catalyst generation [
174
]

Cu, Ag

PH-responsive silk fibroin-based CuO/Ag micro/nano coating polyetheretherketone (PEEK)

Particles were incorporated into the porous surface of PEEK through PDA and silk fibroin layers

Promote antibacterial ability and angiogenesis [
175
]

Cu

CuS@electrospun nanofiber (ENF) composite (ENFC)

Polyelectrolyte complexation and genipin-involved cross-linking reaction

Promote the capillary tube formation of endothelial cells [
176
]

Zn

Zn
2+
cross-linked quaternized cellulose (QC)-sodium alginate (SA) composite sponges

Crosslink QC and SA with Zn
2+

Promote epithelial regeneration and mitigate inflammatory cell infiltration [
177
]

Open in a new tab
Alloy stents can serve as the carriers for metal ions inherently. For bioabsorbable stents, the metal ions released during degradation can exert therapeutic effects locally. Zhao
et al.
prepared a new type of degradable Zn-Mg-Cu alloy scaffold by integrated additive manufacturing. The Zn alloy showed moderate degradation rate. Mg enhanced mechanical strength of Zn alloy, and the released Mg
2+
showed immunoregulation effects. Cu
2+
released during degradation enhanced angiogenesis and anti-inflammation function of the scaffold, which promoted tissue regeneration [
162
].

Polymer scaffolds are extensively studied for tissue engineering. Although the adding of metal ions in polymer is not as straightforward as doping in alloy, many studies have been proceeded to add metal ions or metal-related nanoparticles in organic scaffolds. Wang
et al.
constructed a composite scaffold composed of piezoelectric whitlockite and poly(ε-caprolactone) (PCL) through 3D printing technology. Whitlockite is a natural Mg containing Ca phosphate that has sustained release of Mg
2+
and Ca
2+
[
163
]. Besides, Zhang
et al.
synthesized uniform Zn silicate nanoparticles with spindle-shaped morphology using hydrothermal method and incorporated them into PCL electrospun nanofibers, obtaining a bioactive nanofiber scaffold loaded with Zn
2+
. The continuous release of Zn and silicon ions showed beneficial effects in stimulating vascular regeneration in both
in vivo
and
in vitro
experiments [
164
].

Surface coating technology can increase biocompatibility of biomaterials without affecting the structure and mechanical properties of the scaffolds, it is especially important in improving hemocompatibility for a series of blood-contacting materials. The surface coating of certain metal ions can increase the endothelialization (i.e. Mg
2+
[
80
]) and anti-thrombus effects (i.e. Cu
2+
). One of the most commonly used metal ion functionalization method is the metal-phenol network coating, which is formed by coordinating various polyphenols with metal cations [
165
,
166
]. This strategy is broadly applicable due to its high biocompatibility and high stability.
Others

Besides nanoparticles, hydrogels and scaffolds, many other methods for metal ions delivery are constantly being developed, which are listed in
Table 5
.

Table 5.

Engineering strategies for metal ion delivery based on others

Metal ion

Specific biomaterial

Metal ion loading methods

Effects

Sr, Mg

PLGA micro-cage-like structures loaded with Sr- and Mg-doped hydroxyapatite (HA) (Sr/Mg@HA/PLGA-CAS)

Ion exchange of Sr
2+
/Mg
2+
with Ca
2+
in hydroxyapatite

Assist angiogenesis [
181
]

Zn

Zn-MOF encapsulated degradable MNs array

Encapsulate ZIF-8 into a photo-crosslinked methacrylated hyaluronic acid (MeHA) through the molding method

Accelerate epithelial regeneration and neovascularization [
178
]

Ag, Ca, Zn, Cu

Freeze-thawing CS/ions hydrogel coated gauzes

Freeze-thawing method

Promote granulation formation, collagen deposition and maturation, re-epithelization, angiogenesis and inhibit inflammation [
182
]

Cu

Cu-EGCG capsules

Layer-by-layer assembly through the coordination of EGCG with Cu
2+

Induce the secretion of VEGF, promote angiogenesis and restore local blood supply [
180
]

Cu

Cu-albumin microbubble

The coordination between N-terminal tripeptide chains and Cu
2+

Restore blood vessel density and improve cardiac contractility [
179
,
183
]

Open in a new tab
Microneedles (MNs) is a typical minimally invasive local drug delivery method. Compared with ordinary patches, drugs can penetrate into the matrix of the target location much more easily; compared with direct injection, MNs are more painless and MNs can act as drug reservoirs for sustained release. Yao
et al.
combined MOF and MNs and designed a Zn-MOF-encapsulated degradable MNs array. This MNs array can effectively release Zn
2+
and has been found to significantly accelerate epithelial regeneration and neovascularization [
178
]. However, the use of MNs array for metal ion delivery in CVD therapy has not been widely reported.

Other materials with micron level size have also shown advantages in the delivery of metal ions, because their dimensions are suitable for minimally invasive implantation, and their capacity in loading and releasing metal release are easy to tune. For example, micron sized Cu-albumin microbubbles were prepared for ultrasound-guided organ specific delivery of Cu. The local release of Cu at the ischemic myocardium, ultimately restoring local vascular density and improving cardiac contractility in rhesus monkeys [
179
]. Duan
et al.
synthesized micron level metal polyphenol capsules (Cu-EGCG capsules) by coordinating Epigallocatechin-3-gallate (EGCG) with Cu
2+
. The continuous release of Cu
2+
induce VEGF secretion, promote angiogenesis and restore local blood supply in hindlimb ischemia models [
180
].

As the development of control release materials, more methods with their own characteristics are being developed. The criteria of the strategies will be the translational applications for the treatment of specific CVDs, which is conducive to further improving the treatment effect.
Conclusion and future prospective

Metal ions have shown positive roles in inhibiting oxidative stress, promoting vascular regeneration and regulating ion channels. They also have unique advantages in therapeutic application, such as broad resource, high stability and safety and diverse drug delivery methods. More and more studies have begun to focus on the clinical transformation of metal ions in regenerative medicine and tissue engineering, especially in the cardiovascular field. Strategies for the controlled local delivery of metal ions based on various biomaterials are being designed and have received more and more attentions. Although the current application of metal ion delivery is still focused on skin damage repair and bone repair, with the continuous exploration and discovery of the importance of metal ions in the cardiovascular field, we believe that in the near future, more and more diverse engineering strategies will be applied to the treatment of CVDs.

The delivery strategies of metal ions for biomedical applications are various, most of which use nanoparticles, hydrogels and solid scaffolds as carriers. Different carriers have different application ranges and corresponding advantages and disadvantages. Nanoparticles are widely used in medical imaging, gene and drug delivery, pathogen and protein detection, and tissue engineering [
184
,
185
]. They have good encapsulation performance and can achieve precise treatment through active/passive targeting [
186
]. However, there is a relationship between the size and toxicity of therapeutic nanoparticles, and smaller nanoparticles tend to aggregate, leading to poor biological distribution [
187
,
188
]. Hydrogels are widely explored and applied in cosmetic medicine, wound dressings, drug delivery, disease models, tissue repair and regeneration and other fields [
189
]. They have good biocompatibility and biodegradability, and have the ability to support cell interactions and tissue volume [
190
]. Nevertheless, their hydrophilicity may lead to low encapsulation efficiency of hydrophobic bioactive molecules and drugs, and their highly porous structure may lead to cargo leakage during transportation [
191
]. Solid scaffolds play an important role in cartilage repair, bone tissue engineering, heart repair and drug delivery [
192
]. They have good mechanical strength that the aforementioned carriers do not possess, and their interactions with cells are also conducive to stimulating the formation of functional tissues [
193
,
194
]. However, the application of scaffolds is still limited by their immunogenicity, and due to their significant differences in mechanical and biochemical properties from natural tissues, it is difficult to simulate the microenvironment inside the body well [
195
]. Therefore, when choosing metal ion delivery strategies, their characteristics should be fully considered to achieve safer and more efficient drug delivery.

At present, the supplementation of metal ions is still mainly based on oral foods with relatively high levels, and clinical research on the treatment of CVDs through local delivery of metal ions is still lacking. The current clinical research mainly focuses on the potential therapeutic effects of metal ion concentration changes caused by cyclic drug administration on CVDs. Woods
et al.
conducted a randomized, double-blind controlled study on 2316 suspected acute MI patients and found that receiving intravenous magnesium sulfate significantly reduced early mortality and left ventricular failure rates. The efficacy of magnesium sulfate in reducing early mortality after MI might be attributed to the beneficial cardiovascular effects of Mg
2+
at pharmacological concentrations [
196
]. In addition, clinical studies have also found a beneficial trend of Mg
2+
in reducing the rate of restenosis after percutaneous coronary angioplasty [
197
].

To facilitate translational application of metal ion as therapeutic agent for CVD, the release of metal ion is an important issue. First, due to the varying sensitivity of different tissues to different metal ions, and the difficulty in determining the types and dosages of metal ions that need to be supplemented for different degrees of injury, it is difficult to accurately delineate the concentration range of metal ions that are effective in treating body injuries and have no obvious toxic side effects. In addition, the increase in metal ion concentration caused by the release of local metal ions has certain limitations for combined medication. This is because metal ions can not only form insoluble complexes with drugs, affecting their efficacy, but also react with drugs, affecting their stability. Finally, most metal ions are excreted through organs such as the liver and kidney, making it difficult to determine the potential toxicity of long-term treatment to these organs. Therefore, further research is needed to continuously improve the accuracy of on-demand delivery of metal ions.

The important roles and corresponding mechanisms of many metal ions, such as Cu
2+
, in metabolism and immune regulation are constantly being explored. The emergence of various new technologies and methods is very beneficial for the study of the mechanism of metal ions acting
in vivo
. AlphaFold can utilize deep learning techniques to predict the interactions between metal ions and major proteins through molecular docking simulations [
198
]. In addition, the localization and movement of metal ions within cells can be tracked through artificial intelligence (AI) comparison [
199
], fluorescence probes [
200
] or electron microscopy [
201
]. Moreover, the metabolic process of metal ions in the body can also be tracked through isotopes [
202
]. These technical means can be applied to further exploration of the role of metal ions in CVDs, in order to further determine the types and dosage ranges of metal ions that need to be supplemented for specific CVDs. When the time is ripe, combining the characteristics and advantages of different transmission strategies, local transmission of metal ions may achieve more effective treatment of CVDs.

In this article, we summarize the beneficial effects of different metal ions on the therapy of CVDs. In addition, we focus on the transferability of metal ions in vascular reconstruction and cardiac tissue repair, as well as the corresponding clinical transformation application design at present. Although further researches are still needed to explore the specific mechanisms of metal ions on cardiovascular functions and increase the precision of on-demand delivery before translation, the clinical application prospects of metal ions are still expected.
Contributor Information

Xiaoqian Hong,
Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China.

Geer Tian,
Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China;
Binjiang Institute of Zhejiang University, Hangzhou 310053, China.

Yang Zhu,
Binjiang Institute of Zhejiang University, Hangzhou 310053, China;
MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou 310027, China.

Tanchen Ren,
Department of Cardiology of the Second Affiliated Hospital and State Key Laboratory of Transvascular Implantation Devices, Cardiovascular Key Laboratory of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310009, China.
Funding

This study was financially supported by the National Natural Science Foundation of China (32000971, 12202386 and 82102241) and the Fundamental Research Funds for the Central Universities (2021FZZX001-42).

Conflicts of interest statement
. The authors declare no conflict of interest.
References

1.

Waldron KJ, Rutherford JC, Ford D, Robinson NJ..
Metalloproteins and metal sensing. Nature 2009;460:823–30.

[
DOI
] [
PubMed
] [
Google Scholar
]

2.

Cvetkovic A, Menon AL, Thorgersen MP, Scott JW, Poole FL II, Jenney FE Jr, Lancaster WA, Praissman JL, Shanmukh S, Vaccaro BJ, Trauger SA, Kalisiak E, Apon JV, Siuzdak G, Yannone SM, Tainer JA, Adams MWW..
Microbial metalloproteomes are largely uncharacterized. Nature 2010;466:779–82.

[
DOI
] [
PubMed
] [
Google Scholar
]

3.

Boero M, Terakura K, Tateno M..
Catalytic role of metal ion in the selection of competing reaction paths: a first principles molecular dynamics study of the enzymatic reaction in ribozyme. J Am Chem Soc 2002;124:8949–57.

[
DOI
] [
PubMed
] [
Google Scholar
]

4.

Muchowska KB, Varma SJ, Moran J..
Synthesis and breakdown of universal metabolic precursors promoted by iron. Nature 2019;569:104.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

5.

Li J, Wang Y..
Golgi metal ion homeostasis in human health and diseases. Cells 2022;11:289.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

6.

Li S, Cui Y, Liu H, Tian Y, Wang G, Fan Y, Wang J, Wu D, Wang Y..
Application of bioactive metal ions in the treatment of bone defects. J Mater Chem B 2022;10:9369–88.

[
DOI
] [
PubMed
] [
Google Scholar
]

7.

Wong MYZ, Yap J, Huang W, Tan SY, Yeo KK..
Impact of age and sex on subclinical coronary atherosclerosis in a healthy Asian population. JACC Asia 2021;1:93–102.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

8.

Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–22.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

9.

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW..
2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2022;145:E895–1032.

[
DOI
] [
PubMed
] [
Google Scholar
]

10.

Hori M, Nishida K..
Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res 2009;81:457–64.

[
DOI
] [
PubMed
] [
Google Scholar
]

11.

Stuart SDF, De Jesus NM, Lindsey ML, Ripplinger CM..
The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction. J Mol Cell Cardiol 2016;91:114–22.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

12.

Zhang Z, Dalan R, Hu Z, Wang J-W, Chew NW, Poh K-K, Tan R-S, Soong TW, Dai Y, Ye L, Chen X..
Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease. Adv Mater 2022;34:e2202169.
[
DOI
] [
PubMed
] [
Google Scholar
]

13.

Deng K, Tang Y, Xiao Y, Zhong D, Zhang H, Fang W, Shen L, Wang Z, Pan J, Lu Y, Chen C, Gao Y, Jin Q, Zhuang L, Wan H, Zhuang L, Wang P, Zhai J, Ren T, Hu Q, Lang M, Zhang Y, Wang H, Zhou M, Gao C, Zhang L, Zhu Y..
A biodegradable, flexible photonic patch for in vivo phototherapy. Nat Commun 2023;14:3069.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

14.

Wang L, Liu Y, Ye G, He Y, Li B, Guan Y, Gong B, Mequanint K, Xing MMQ, Qiu X..
Injectable and conductive cardiac patches repair infarcted myocardium in rats and minipigs. Nat Biomed Eng 2021;5:1157–73.

[
DOI
] [
PubMed
] [
Google Scholar
]

15.

Zhu Y, Matsumura Y, Velayutham M, Foley LM, Hitchens TK, Wagner WR..
Reactive oxygen species scavenging with a biodegradable, thermally responsive hydrogel compatible with soft tissue injection. Biomaterials 2018;177:98–112.

[
DOI
] [
PubMed
] [
Google Scholar
]

16.

Ding H, Ding J, Liu Q, Lin J, He M, Wu X, Chen X, Xiao C, Ren T, Zhu Y, Gao C, Hu X, Ja W..
Mesenchymal stem cells encapsulated in a reactive oxygen species-scavenging and O-2-generating injectable hydrogel for myocardial infarction treatment. Chem Eng J 2022;433.
[
Google Scholar
]

17.

Zhang L, Liu G, Lv K, Xin J, Wang Y, Zhao J, Hu W, Xiao C, Zhu K, Zhu L, Nan J, Feng Y, Zhu H, Chen W, Zhu W, Zhang J, Wang Ja Wang B, Hu X..
Surface-anchored nanogel coating endows stem cells with stress resistance and reparative potency via turning down the cytokine-receptor binding pathways. Adv Sci (Weinh) 2021;8:2003348.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

18.

Hu S, Li Z, Shen D, Zhu D, Huang K, Su T, Dinh P-U, Cores J, Cheng K..
Exosome-eluting stents for vascular healing after ischaemic injury. Nat Biomed Eng 2021;5:1239–

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

19.

Zhu Y, Hideyoshi S, Jiang H, Matsumura Y, Dziki JL, LoPresti ST, Huleihel L, Faria GNF, Fuhrman LC, Lodono R, Badylak SF, Wagner WR..
Injectable, porous, biohybrid hydrogels incorporating decellularized tissue components for soft tissue applications. Acta Biomater 2018;73:112–26.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

20.

Chen W, Wang C, Liu W, Zhao B, Zeng Z, Long F, Wang C, Li S, Lin N, Zhou J..
A matrix-metalloproteinase-responsive hydrogel system for modulating the immune microenvironment in myocardial infarction. Adv Mater 2023;35:e2209041.

[
DOI
] [
PubMed
] [
Google Scholar
]

21.

Murphy E, Liu J..
Mitochondrial calcium and reactive oxygen species in cardiovascular disease. Cardiovasc Res 2023;119:1105–16.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

22.

Hu H, Nan J, Sun Y, Zhu D, Xiao C, Wang Y, Zhu L, Wu Y, Zhao J, Wu R, Chen J, Yu H, Hu X, Zhu W, Wang J..
Electron leak from NDUFA13 within mitochondrial complex I attenuates ischemia-reperfusion injury via dimerized STAT3. Proc Natl Acad Sci USA 2017;114:11908–13.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

23.

Xu H, She P, Zhao Z, Ma B, Li G, Wang Y..
Duplex responsive nanoplatform with cascade targeting for atherosclerosis photoacoustic diagnosis and multichannel combination therapy. Adv Mater 2023;35:e2300439.
[
DOI
] [
PubMed
] [
Google Scholar
]

24.

Jiang L, Yin X, Chen Y-H, Chen Y, Jiang W, Zheng H, Huang F-Q, Liu B, Zhou W, Qi L-W, Li J..
Proteomic analysis reveals ginsenoside Rb1 attenuates myocardial ischemia/reperfusion injury through inhibiting ROS production from mitochondrial complex I. Theranostics 2021;11:1703–20.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

25.

Sun Q, Ma H, Zhang J, You B, Gong X, Zhou X, Chen J, Zhang G, Huang J, Huang Q, Yang Y, Bai AK..
Y. A self-sustaining antioxidant strategy for effective treatment of myocardial infarction. Adv Sci (Weinh) 2023;10:e2204999.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

26.

Yao Y, Li A, Wang S, Lu Y, Xie J, Zhang H, Zhang D, Ding J, Wang Z, Tu C, Shen L, Zhuang L, Zhu Y, Gao C..
Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo. Biomaterials 2022;282:121382.

[
DOI
] [
PubMed
] [
Google Scholar
]

27.

Gout E, Rebeille F, Douce R, Bligny R..
Interplay of Mg
2+
, ADP, and ATP in the cytosol and mitochondria: unravelling the role of Mg
2+
in cell respiration. Proc Natl Acad Sci USA 2014;111:E4560–E4567.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

28.

Kramer JH, Mak IT, Phillips TM, Weglicki WB..
Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myoccardial tolerance to postischemic stress. Exp Biol Med 2003;228:665–73.
[
DOI
] [
PubMed
] [
Google Scholar
]

29.

Bussiere FI, Tridon A, Zimowska W, Mazur A, Rayssiguier Y..
Increase in complement component C3 is an early response to experimental magnesium deficiency in rats. Life Sci 2003;73:499–507.

[
DOI
] [
PubMed
] [
Google Scholar
]

30.

Petrovic J, Stanic D, Dmitrasinovic G, Plecas-Solarovic B, Ignjatovic S, Batinic B, Popovic D, Pesic V..
Magnesium supplementation diminishes peripheral blood lymphocyte DNA oxidative damage in athletes and sedentary young man. Oxid Med Cell Longev 2016;2016:2019643.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

31.

Liu M, Jeong E-M, Liu H, Xie A, So EY, Shi G, Jeong GE, Zhou A, Dudley SC Jr, Magnesium supplementation improves diabetic mitochondrial and cardiac diastolic function. JCI Insight 2019;4:e123182.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

32.

Shen X, Fang K, Yie KHR, Zhou Z, Shen Y, Wu S, Zhu Y, Deng Z, Ma P, Ma J, Liu J..
High proportion strontium-doped micro-arc oxidation coatings enhance early osseointegration of titanium in osteoporosis by anti-oxidative stress pathway. Bioact Mater 2022;10:405–19.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

33.

Zhou C, Chen YQ, Zhu YH, Lin GF, Zhang LF, Liu XC, He FM..
Antiadipogenesis and osseointegration of strontium-doped implant surfaces. J Dent Res 2019;98:795–802.

[
DOI
] [
PubMed
] [
Google Scholar
]

34.

Barrioni BR, Norris E, Li S, Naruphontjirakul P, Jones JR, MdM P..
Osteogenic potential of sol-gel bioactive glasses containing manganese. J Mater Sci Mater Med 2019;30:86.

[
DOI
] [
PubMed
] [
Google Scholar
]

35.

Li J, Deng C, Liang W, Kang F, Bai Y, Ma B, Wu C, Dong S..
Mn-containing bioceramics inhibit osteoclastogenesis and promote osteoporotic bone regeneration via scavenging ROS. Bioact Mater 2021;6:3839–50.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

36.

Liu S, Pi J, Zhang Q..
Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol 2022;54:102389.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

37.

Adinolfi S, Patinen T, Deen AJ, Pitkanen S, Harkonen J, Kansanen E, Kublbeck J, Levonen A-L..
The KEAP1-NRF2 pathway: targets for therapy and role in cancer. Redox Biol 2023;63:102726.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

38.

Jarosz M, Olbert M, Wyszogrodzka G, Mlyniec K, Librowski T..
Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-kappa B signaling. Inflammopharmacology 2017; 25:11–24.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

39.

Korichneva I.
Zinc dynamics in the myocardial redox signaling network. Antioxid Redox Signal 2006;8:1707–21.

[
DOI
] [
PubMed
] [
Google Scholar
]

40.

Sangyong C, Xian L, Zui P..
Zinc deficiency and cellular oxidative stress: prognostic implications in cardiovascular diseases. Acta Pharmacologica Sinica 2018;39:1120–32.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

41.

Manford AG, Mena EL, Shih KY, Gee CL, McMinimy R, Martinez-Gonzalez B, Sherriff R, Lew B, Zoltek M, Rodriguez-Perez F, Woldesenbet M, Kuriyan J, Rape M..
Structural basis and regulation of the reductive stress response. Cell 2021;184:5375.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

42.

Odatsu T, Kuroshima S, Shinohara A, Valanezhad A, Sawase T..
Lactoferrin with Zn-ion protects and recovers fibroblast from H
2
O
2
-induced oxidative damage. Int J Biol Macromol 2021;190:368–74.

[
DOI
] [
PubMed
] [
Google Scholar
]

43.

Allen-Redpath K, Ou O, Beattie JH, Kwun I-S, Feldmann J, Nixon GF..
Marginal dietary zinc deficiency in vivo induces vascular smooth muscle cell apoptosis in large arteries. Cardiovasc Res 2013;99:525–34.

[
DOI
] [
PubMed
] [
Google Scholar
]

44.

Prasad AS, Beck FWJ, Bao B, Fitzgerald JT, Snell DC, Steinberg JD, Cardozo LJ..
Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress. Am J Clin Nutr 2007;85:837–44.

[
DOI
] [
PubMed
] [
Google Scholar
]

45.

Oteiza PI, Clegg MS, Zago MP, Keen CL..
Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells. Free Radic Biol Med 2000;28:1091–9.

[
DOI
] [
PubMed
] [
Google Scholar
]

46.

Kojima-Yuasa A, Umeda K, Olikita T, Kennedy DO, Nishiguchi S, Matsui-Yuasa I..
Role of reactive oxygen species in zinc deficiency-induced hepatic stellate cell activation. Free Radic Biol Med 2005;39:631–40.

[
DOI
] [
PubMed
] [
Google Scholar
]

47.

Eide DJ.
The oxidative stress of zinc deficiency. Metallomics 2011;3:1124–9.

[
DOI
] [
PubMed
] [
Google Scholar
]

48.

Kim B-E, Nevitt T, Thiele DJ..
Mechanisms for copper acquisition, distribution and regulation. Nat Chem Biol 2008;4:176–85.

[
DOI
] [
PubMed
] [
Google Scholar
]

49.

Im G-B, Kim YG, Yoo TY, Kim YH, Kim K, Hyun J, Soh M, Hyeon T, Bhang SH..
Ceria nanoparticles as copper chaperones that activate SOD1 for synergistic antioxidant therapy to treat ischemic vascular diseases. Adv Mater 2023;35:e2208989.
[
DOI
] [
PubMed
] [
Google Scholar
]

50.

Yang L, Yang P, Lip GYH, Ren J..
Copper homeostasis and cuproptosis in cardiovascular disease therapeutics. Trends Pharmacol Sci 2023;44:573–85.

[
DOI
] [
PubMed
] [
Google Scholar
]

51.

Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J..
Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 2022;43:2549.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

52.

Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, Wang Y, Fu C, Jiang Y, He C, Wei Q..
Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022;7:78.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

53.

Li Z, Zhu D, Hui Q, Bi J, Yu B, Huang Z, Hu S, Wang Z, Caranasos T, Rossi J, Li X, Cheng K, Wang X..
Injection of ROS-Responsive hydrogel loaded with basic fibroblast growth factor into the pericardial cavity for heart repair. Adv Funct Mater 2021;31:2004377.
[
Google Scholar
]

54.

Zhu K, Wu Q, Ni C, Zhang P, Zhong Z, Wu Y, Wang Y, Xu Y, Kong M, Cheng H, Tao Z, Yang Q, Liang H, Jiang Y, Li Q, Zhao J, Huang J, Zhang F, Chen Q, Li Y, Chen J, Zhu W, Yu H, Zhang J, Yang H-T, Hu X, Wang J..
Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates. Circ Res 2018;122:958–69.

[
DOI
] [
PubMed
] [
Google Scholar
]

55.

Li Q, Xu Y, Lv K, Wang Y, Zhong Z, Xiao C, Zhu K, Ni C, Wang K, Kong M, Li X, Fan Y, Zhang F, Chen Q, Li Y, Li Q, Liu C, Zhu J, Zhong S, Wang J, Chen Y, Zhao J, Zhu D, Wu R, Chen J, Zhu W, Yu H, Ardehali R, Zhang J, Wang J, Hu X..
Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates. Sci Transl Med 2021;13:eabb0202.
[
DOI
] [
PubMed
] [
Google Scholar
]

56.

Gaspar D, Peixoto R, De Pieri A, Striegl B, Zeugolis DI, Raghunath M..
Local pharmacological induction of angiogenesis: drugs for cells and cells as drugs. Adv Drug Deliv Rev 2019;146:126–54.

[
DOI
] [
PubMed
] [
Google Scholar
]

57.

Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, Eaton JK, Frenkel E, Kocak M, Corsello SM, Lutsenko S, Kanarek N, Santagata S, Golub TR..
Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 2022;375:1254.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

58.

Li K, Li C, Xiao Y, Wang T, Kang YJ..
The loss of copper is associated with the increase in copper metabolism MURR domain 1 in ischemic hearts of mice. Exp Biol Med 2018;243:780–5.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

59.

Hu GF.
Copper stimulates proliferation of human endothelial cells under culture. J Cell Biochem 1998;69:326–35.

[
DOI
] [
PubMed
] [
Google Scholar
]

60.

Narayanan G, Bharathidevi SR, Vuyyuru H, Muthuvel B, Natrajan SK..
CTR1 silencing inhibits angiogenesis by limiting copper entry into endothelial cells. PLoS One 2013;8:e71982.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

61.

Li Q-f, Ding X-q, Kang YJ..
Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor. J Nutr Biochem 2014;25:44–9.

[
DOI
] [
PubMed
] [
Google Scholar
]

62.

Liu X, Zhang W, Wu Z, Yang Y, Kang YJ..
Copper levels affect targeting of hypoxia-inducible factor 1 alpha to the promoters of hypoxia-regulated genes. J Biol Chem 2018;293:14669–77.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

63.

Xiao Y, Wang T, Song X, Yang D, Chu Q, Kang YJ..
Copper promotion of myocardial regeneration. Exp Biol Med 2020;245:911–21.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

64.

Rajendran S, Shen X, Glawe J, Kolluru GK, Kevil CG..
Nitric oxide and hydrogen sulfide regulation of ischemic vascular growth and remodeling. Compr Physiol 2019;9:1213–47.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

65.

Tousoulis D, Kampoli A-M, Papageorgiou CTN, Stefanadis C..
The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10:4–18.

[
DOI
] [
PubMed
] [
Google Scholar
]

66.

Yetik-Anacak G, Catravas JD..
Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol 2006;45:268–76.

[
DOI
] [
PubMed
] [
Google Scholar
]

67.

Lyu N, Du Z, Qiu H, Gao P, Yao Q, Xiong K, Tu Q, Li X, Chen B, Wang M, Pan G, Huang N, Yang Z..
Mimicking the nitric oxide-releasing and glycocalyx functions of endothelium on vascular stent surfaces. Adv Sci (Weinh) 2020;7:2002330.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

68.

Ma Q, Shi X, Tan X, Wang R, Xiong K, Maitz MF, Cui Y, Hu Z, Tu Q, Huang N, Shen L, Yang Z..
Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents. Bioact Mater 2021;6:4786–800.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

69.

Yu H, Qiu H, Ma W, Maitz MF, Tu Q, Xiong K, Chen J, Huang N, Yang Z..
Endothelium-mimicking surface combats thrombosis and biofouling via synergistic long- and short-distance defense strategy. Small 2021;17:e2100729.
[
DOI
] [
PubMed
] [
Google Scholar
]

70.

Yu H, Yu S, Qiu H, Gao P, Chen Y, Zhao X, Tu Q, Zhou M, Cai L, Huang N, Xiong K, Yang Z..
Nitric oxide-generating compound and bio-clickable peptide mimic for synergistically tailoring surface anti-thrombogenic and anti-microbial dual-functions. Bioact Mater 2021;6:1618–27.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

71.

Yang L, Li L, Wu H, Zhang B, Luo R, Wang Y..
Catechol-mediated and copper-incorporated multilayer coating: an endothelium-mimetic approach for blood-contacting devices. J Control Release 2020;321:59–70.

[
DOI
] [
PubMed
] [
Google Scholar
]

72.

Wang Z, Zhao Y, Zhao Y, Zhang Y, Yao X, Hang R..
Exosomes secreted by macrophages upon copper ion stimulation can promote angiogenesis. Mater Sci Eng C Mater Biol Appl 2021;123:111981.

[
DOI
] [
PubMed
] [
Google Scholar
]

73.

Tian J, Wong KKY, Ho C-M, Lok C-N, Yu W-Y, Che C-M, Chiu J-F, Tam PKH..
Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem 2007;2:129–36.

[
DOI
] [
PubMed
] [
Google Scholar
]

74.

Gu Y, Zhang J, Zhang X, Liang G, Xu T, Niu W..
Three-dimensional printed Mg-doped beta-TCP bone tissue engineering scaffolds: effects of magnesium ion concentration on osteogenesis and angiogenesis in vitro. Tissue Eng Regen Med 2019;16:415–29.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

75.

Liu W, Guo S, Tang Z, Wei X, Gao P, Wang N, Li X, Guo Z..
Magnesium promotes bone formation and angiogenesis by enhancing MC3T3-E1 secretion of PDGF-BB. Biochem Biophys Res Commun 2020;528:664–70.

[
DOI
] [
PubMed
] [
Google Scholar
]

76.

Qin H, Weng J, Zhou B, Zhang W, Li G, Chen Y, Qi T, Zhu Y, Yu F, Zeng H..
Magnesium ions promote in vitro rat bone marrow stromal cell angiogenesis through notch signaling. Biol Trace Elem Res 2023;201:2823–42.

[
DOI
] [
PubMed
] [
Google Scholar
]

77.

Bobe K, Willbold E, Haupt M, Reebmann M, Morgenthal I, Andersen O, Studnitzky T, Nellesen J, Tillmann W, Vogt C, Vano-Herrera K, Witte F..
Biodegradable open-porous scaffolds made of sintered magnesium W4 and WZ21 short fibres show biocompatibility in vitro and in long-term in vivo evaluation. Acta Biomater 2022;148:389–404.

[
DOI
] [
PubMed
] [
Google Scholar
]

78.

Zheng Z, Chen Y, Hong H, Shen Y, Wang Y, Sun J, Wang X..
The “Yin and Yang” of immunomodulatory magnesium-enriched graphene oxide nanoscrolls decorated biomimetic scaffolds in promoting bone regeneration. Adv Healthc Mater 2021;10:e2000631.
[
DOI
] [
PubMed
] [
Google Scholar
]

79.

Ma L, Cheng S, Ji X, Zhou Y, Zhang Y, Li Q, Tan C, Peng F, Zhang Y, Huang W..
Immobilizing magnesium ions on 3D printed porous tantalum scaffolds with polydopamine for improved vascularization and osteogenesis. Mater Sci Eng C Mater Biol Appl 2020;117:111303.

[
DOI
] [
PubMed
] [
Google Scholar
]

80.

Zhang B, Yao R, Li L, Wang Y, Luo R, Yang L, Wang Y..
Green tea polyphenol induced Mg
2+
-rich multilayer conversion coating: toward enhanced corrosion resistance and promoted in situ endothelialization of AZ31 for potential cardiovascular applications. ACS Appl Mater Interfaces 2019;11:41165–77.

[
DOI
] [
PubMed
] [
Google Scholar
]

81.

Simonsen LO, Harbak H, Bennekou P..
Cobalt metabolism and toxicology-A brief update. Sci Total Environ 2012;432:210–5.

[
DOI
] [
PubMed
] [
Google Scholar
]

82.

Boldbaatar K, Dashnyam K, Knowles JC, Lee H-H, Lee J-H, Kim H-W..
Dual-ion delivery for synergistic angiogenesis and bactericidal capacity with silica-based microsphere. Acta Biomater 2019;83:322–33.

[
DOI
] [
PubMed
] [
Google Scholar
]

83.

Zhang H, Zhao Y, Zhang Y, Hang R, Yao X, Hang R..
Exosomes derived from macrophages upon cobalt ion stimulation promote angiogenesis. Colloids Surf B Biointerfaces 2021;203:111742.
[
DOI
] [
PubMed
] [
Google Scholar
]

84.

Birgani ZT, Gharraee N, Malhotra A, van Blitterswijk CA, Habibovic P..
Combinatorial incorporation of fluoride and cobalt ions into calcium phosphates to stimulate osteogenesis and angiogenesis. Biomed Mater 2016;11:015020.

[
DOI
] [
PubMed
] [
Google Scholar
]

85.

Li T, He H, Yang Z, Wang J, Zhang Y, He G, Huang J, Song D, Ni J, Zhou X, Zhu J, Ding M..
Strontium-doped gelatin scaffolds promote M2 macrophage switch and angiogenesis through modulating the polarization of neutrophils. Biomater Sci 2021;9:2931–46.

[
DOI
] [
PubMed
] [
Google Scholar
]

86.

Mao L, Xia L, Chang J, Liu J, Jiang L, Wu C, Fang B..
The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration. Acta Biomater 2017;61:217–32.

[
DOI
] [
PubMed
] [
Google Scholar
]

87.

Luo R, Huang Y, Yuan X, Yuan Z, Zhang L, Han J, Zhao Y, Cai Q..
Controlled co-delivery system of magnesium and lanthanum ions for vascularized bone regeneration. Biomed Mater 2021;16:065024.
[
DOI
] [
PubMed
] [
Google Scholar
]

88.

Dixon RE, Navedo MF, Binder MD, Santana LF..
Mechanisms and physiological implications of cooperative gating of clustered ion channels. Physiol Rev 2022;102:1159–210.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

89.

Varro A, Tomek J, Nagy N, Virag L, Passini E, Rodriguez B, Baczko I..
Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior. Physiol Rev 2021;101:1083–176.

[
DOI
] [
PubMed
] [
Google Scholar
]

90.

Mesirca P, Nakao S, Nissen SD, Forte G, Anderson C, Trussell T, Li J, Cox C, Zi M, Logantha S, Yaar S, Cartensen H, Bidaud I, Stuart L, Soattin L, Morris GM, Martins P, Cartwright EJ, Oceandy D, Mangoni ME, Jespersen T, Buhl R, Dobrzynski H, Boyett MR, D'Souza A..
Intrinsic electrical remodeling underlies atrioventricular block in athletes. Circ Res 2021;129:E1–20.

[
DOI
] [
PubMed
] [
Google Scholar
]

91.

Cheng J, Wen J, Wang N, Wang C, Xu Q, Yang Y..
Ion channels and vascular diseases. Arterioscler Thromb Vasc Biol 2019;39:E146–56.

[
DOI
] [
PubMed
] [
Google Scholar
]

92.

Tykocki NR, Boerman EM, Jackson WF..
Smooth muscle ion channels and regulation of vascular tone in resistance arteries and arterioles. Compr Physiol 2017;7:485–581.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

93.

Daghbouche-Rubio N, Ramon Lopez-Lopez J, Teresa Perez-Garcia M, Cidad P..
Vascular smooth muscle ion channels in essential hypertension. Front Physiol 2022;13:1016175.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

94.

Chen Y-L, Daneva Z, Kuppusamy M, Ottolini M, Baker TM, Klimentova E, Shah SA, Sokolowski JD, Park MS, Sonkusare SK..
Novel smooth muscle Ca2+-signaling nanodomains in blood pressure regulation. Circulation 2022;146:548–64.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

95.

Bassetto CAZ, Costa F, Guardiani C, Bezanilla F, Giacomello A..
Noncanonical electromechanical coupling paths in cardiac hERG potassium channel. Nat Commun 2023;14:1110.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

96.

Ohanyan V, Raph SM, Dwenger MM, Hu X, Pucci T, Mack G, Moore JB, Chilian WM, Bhatnagar A, Nystoriak MA..
Myocardial blood flow control by oxygen sensing vascular Kv beta proteins. Circ Res 2021;128:738–51.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

97.

Wang D, Zhu Z-L, Lin D-C, Zheng S-Y, Chuang K-H, Gui L-X, Yao R-H, Zhu W-J, Sham JSK, Lin M-J..
Magnesium supplementation attenuates pulmonary hypertension via regulation of magnesium transporters. Hypertension 2021;77:617–31.

[
DOI
] [
PubMed
] [
Google Scholar
]

98.

Mubagwa K, Gwanyanya A, Zakharov S, Macianskiene R..
Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium. Arch Biochem Biophys 2007;458:73–89.

[
DOI
] [
PubMed
] [
Google Scholar
]

99.

Brunet S, Scheuer T, Klevit R, Catterall WA..
Modulation of Ca(V)1.2 channels by Mg2+ acting at an EF-hand motif in the COOH-terminal domain. J Gen Physiol 2005;126:311–23.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

100.

de Baaij JHF, Hoenderop JGJ, Bindels RJM..
Magnesium in man: implications for health and disease. Physiol Rev 2015;95:1–46.

[
DOI
] [
PubMed
] [
Google Scholar
]

101.

Alvarez-Collazo J, Diaz-Garcia CM, Lopez-Medina AI, Vassort G, Alvarez JL..
Zinc modulation of basal and beta-adrenergically stimulated L-type Ca2+ current in rat ventricular cardiomyocytes: consequences in cardiac diseases. Pflugers Arch 2012;464:459–70.

[
DOI
] [
PubMed
] [
Google Scholar
]

102.

Betrie AH, Brock JA, Harraz OF, Bush AI, He G-W, Nelson MT, Angus JA, Wright CE, Ayton S..
Zinc drives vasorelaxation by acting in sensory nerves, endothelium and smooth muscle. Nat Commun 2021;12:3296.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

103.

Lim B, Kim KS, Na K..
pH-Responsive zinc ion regulating immunomodulatory nanoparticles for effective cancer immunotherapy. Biomacromolecules 2023;24:4263–73.

[
DOI
] [
PubMed
] [
Google Scholar
]

104.

Shahi A, Aslani S, Ataollahi M, Mahmoudi M..
The role of magnesium in different inflammatory diseases. Inflammopharmacology 2019;27:649–61.

[
DOI
] [
PubMed
] [
Google Scholar
]

105.

Younis NS, Mohamed ME, El Semary NA..
Green synthesis of silver nanoparticles by the cyanobacteria
Synechocystis
sp.: characterization, antimicrobial and diabetic wound-healing actions. Mar Drugs 2022;20:56.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

106.

Kostov K, Halacheva L..
Role of magnesium deficiency in promoting atherosclerosis, endothelial dysfunction, and arterial stiffening as risk factors for hypertension. Int J Mol Sci 2018;19:1724.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

107.

Frangogiannis NG.
Pathophysiology of myocardial infarction. Compr Physiol 2015;5:1841–75.

[
DOI
] [
PubMed
] [
Google Scholar
]

108.

Nielsen FH.
Magnesium, inflammation, and obesity in chronic disease. Nutr Rev 2010;68:333–40.

[
DOI
] [
PubMed
] [
Google Scholar
]

109.

Beattie JH, Gordon M-J, Duthie SJ, McNeil CJ, Horgan GW, Nixon GF, Feldmann J, Kwun I-S..
Suboptimal dietary zinc intake promotes vascular inflammation and atherogenesis in a mouse model of atherosclerosis. Mol Nutr Food Res 2012;56:1097–105.

[
DOI
] [
PubMed
] [
Google Scholar
]

110.

Novotny JA, Peterson CA..
Molybdenum. Adv Nutr 2018;9:272–3.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

111.

Masood N, Ahmed R, Tariq M, Ahmed Z, Masoud MS, Ali I, Asghar R, Andleeb A, Hasan A..
Silver nanoparticle impregnated chitosan-PEG hydrogel enhances wound healing in diabetes induced rabbits. Int J Pharm 2019;559:23–36.

[
DOI
] [
PubMed
] [
Google Scholar
]

112.

Amer TAM, Palanisamy S, So PB, Vijayaraghavan P, Tzou S-C, Lu T-T, Lin C-H, Wang Y-M..
Sustained releasable copper and zinc biogenic ions Co-assembled in metal-organic frameworks reinforced bacterial eradication and wound mitigation in diabetic mice. Bioconjug Chem 2023;34:1688–703.

[
DOI
] [
PubMed
] [
Google Scholar
]

113.

Badhe RV, Akinfosile O, Bijukumar D, Barba M, Mathew MT..
Systemic toxicity eliciting metal ion levels from metallic implants and orthopedic devices—a mini review. Toxicol Lett 2021;350:213–24.

[
DOI
] [
PubMed
] [
Google Scholar
]

114.

Van Laecke S.
Hypomagnesemia and hypermagnesemia. Acta Clin Belg 2019;74:41–7.

[
DOI
] [
PubMed
] [
Google Scholar
]

115.

Kardos J, Heja L, Simon A, Jablonkai I, Kovacs R, Jemnitz K..
Copper signalling: causes and consequences. Cell Commun Signal 2018;16:71.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

116.

Trumbo P, Yates AA, Schlicker S, Poos M..
Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc 2001;101:294–301.

[
DOI
] [
PubMed
] [
Google Scholar
]

117.

Mohammadifard N, Humphries KH, Gotay C, Mena-Sanchez G, Salas-Salvado J, Esmaillzadeh A, Ignaszewski A, Sarrafzadegan N..
Trace minerals intake: risks and benefits for cardiovascular health. Crit Rev Food Sci Nutr 2019;59:1334–46.

[
DOI
] [
PubMed
] [
Google Scholar
]

118.

Li Q, Gao Y, Zhang J, Tang Y, Sun Y, Wu L, Wu H, Shen M, Liu X, Han L, Xu Z..
Crosslinking and functionalization of acellular patches via the self-assembly of copper@tea polyphenol nanoparticles. Regen Biomater 2022;9:rbac030.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

119.

Cho S, Discher DE, Leong KW, Vunjak-Novakovic G, Wu JC..
Challenges and opportunities for the next generation of cardiovascular tissue engineering. Nat Methods 2022;19:1064–71.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

120.

Zhuang RZ, Lock R, Liu B, Vunjak-Novakovic G..
Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances. Nat Biomed Eng 2022;6:327–38.

[
DOI
] [
PubMed
] [
Google Scholar
]

121.

Yuan Z, Wan Z, Gao C, Wang Y, Huang J, Cai Q..
Controlled magnesium ion delivery system for in situ bone tissue engineering. J Control Release 2022;350:360–76.

[
DOI
] [
PubMed
] [
Google Scholar
]

122.

Shi H-T, Huang Z-H, Xu T-Z, Sun A-J, Ge J-B..
New diagnostic and therapeutic strategies for myocardial infarction via nanomaterials. EBioMedicine 2022;78:103968.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

123.

Saludas L, Pascual-Gil S, Roli F, Garbayo E, Blanco-Prieto MJ..
Heart tissue repair and cardioprotection using drug delivery systems. Maturitas 2018;110:1–9.

[
DOI
] [
PubMed
] [
Google Scholar
]

124.

Sharma AR, Lee Y-H, Bat-Ulzii A, Bhattacharya M, Chakraborty C, Lee S-S..
Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications. J Nanobiotechnology 2022;20:501.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

125.

Shim MK, Yang S, Sun I-C, Kim K..
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer immunotherapy: preclinical evidence for safe and effective drug delivery. Adv Drug Deliv Rev 2022;183:114177.

[
DOI
] [
PubMed
] [
Google Scholar
]

126.

Vargason AM, Anselmo AC, Mitragotri S..
The evolution of commercial drug delivery technologies. Nat Biomed Eng 2021;5:951–67.

[
DOI
] [
PubMed
] [
Google Scholar
]

127.

Liu T, Xiao B, Xiang F, Tan J, Chen Z, Zhang X, Wu C, Mao Z, Luo G, Chen X, Deng J..
Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat Commun 2020;11:2788.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

128.

Banerjee R, Phan A, Wang B, Knobler C, Furukawa H, O'Keeffe M, Yaghi OM..
High-throughput synthesis of zeolitic imidazolate frameworks and application to CO
2
capture. Science 2008;319:939–43.

[
DOI
] [
PubMed
] [
Google Scholar
]

129.

Banerjee R, Furukawa H, Britt D, Knobler C, O'Keeffe M, Yaghi OM..
Control of pore size and functionality in isoreticular zeolitic imidazolate frameworks and their carbon dioxide selective capture properties. J Am Chem Soc 2009;131:3875.

[
DOI
] [
PubMed
] [
Google Scholar
]

130.

Huang XC, Lin YY, Zhang JP, Chen XM..
Ligand-directed strategy for zeolite-type metal-organic frameworks: zinc(II) imidazolates with unusual zeolitic topologies. Angew Chem Int Ed Engl 2006;45:1557–9.

[
DOI
] [
PubMed
] [
Google Scholar
]

131.

Sheng J, Zu Z, Zhang Y, Zhu H, Qi J, Zheng T, Tian Y, Zhang L..
Targeted therapy of atherosclerosis by zeolitic imidazolate framework-8 nanoparticles loaded with losartan potassium via simultaneous lipid-scavenging and anti-inflammation. J Mater Chem B 2022;10:5925–37.

[
DOI
] [
PubMed
] [
Google Scholar
]

132.

Lin Z, Liu L, Wang W, Jia L, Shen Y, Zhang X, Ge D, Shi W, Sun Y..
The role and mechanism of polydopamine and cuttlefish ink melanin carrying copper ion nanoparticles in antibacterial properties and promoting wound healing. Biomater Sci 2021;9:5951–64.

[
DOI
] [
PubMed
] [
Google Scholar
]

133.

Zhang X, Zhang Y, Zhang R, Jiang X, Midgley AC, Liu Q, Kang H, Wu J, Khalique A, Qian M, An D, Huang J, Ou L, Zhao Q, Zhuang J, Yan X, Kong D, Huang X..
Biomimetic design of artificial hybrid nanocells for boosted vascular regeneration in ischemic tissues. Adv Mater 2022;34:e2110352.
[
DOI
] [
PubMed
] [
Google Scholar
]

134.

Shu X, Liao J, Wang L, Shi Q, Xie X..
Osteogenic, angiogenic, and antibacterial bioactive nano-hydroxyapatite Co-synthesized using gamma-polyglutamic acid and copper. ACS Biomater Sci Eng 2020;6:1920–30.

[
DOI
] [
PubMed
] [
Google Scholar
]

135.

Zhang Y, Khalique A, Du X, Gao Z, Wu J, Zhang X, Zhang R, Sun Z, Liu Q, Xu Z, Midgley AC, Wang L, Yan X, Zhuang J, Kong D, Huang X..
Biomimetic design of mitochondria-targeted hybrid nanozymes as superoxide scavengers. Adv Mater 2021;33:e2006570.
[
DOI
] [
PubMed
] [
Google Scholar
]

136.

Abdel-Magied N, Shedid SM..
Impact of zinc oxide nanoparticles on thioredoxin-interacting protein and asymmetric dimethylarginine as biochemical indicators of cardiovascular disorders in gamma-irradiated rats. Environ Toxicol 2020;35:430–42.

[
DOI
] [
PubMed
] [
Google Scholar
]

137.

Shao Z, Li R, Shao D, Tang H, Han Y..
Albumin-based Zn (II)-quercetin enzyme mimic scavenging ROS for protection against cardiotoxicity induced by doxorubicin. Pharmaceuticals (Basel) 2022;15:1524.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

138.

Alosaimi M, Abd-Elhakim YM, Mohamed AA-R, Metwally MMM, Khamis T, Alansari WS, Eskandrani AA, Essawi WM, Awad MM, El-Shaer RAA, Ibrahim S, Nassan MA, Metwally AS..
Green synthesized zinc oxide nanoparticles attenuate acrylamide-induced cardiac injury via controlling endoplasmic reticulum stress-associated apoptosis through ATF3/CHOP/BCL2 signaling in rats. Biol Trace Elem Res 2023.
[
DOI
] [
PubMed
] [
Google Scholar
]

139.

Zhang Z, Li W, Chang D, Wei Z, Wang E, Yu J, Xu Y, Que Y, Chen Y, Fan C, Ma B, Zhou Y, Huan Z, Yang C, Guo F, Chang J..
A combination therapy for androgenic alopecia based on quercetin and zinc/copper dual-doped mesoporous silica nanocomposite microneedle patch. Bioact Mater 2023;24:81–95.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

140.

Xu C, Lee W, Dai G, Hong Y..
Highly elastic biodegradable single-network hydrogel for cell printing. ACS Appl Mater Interfaces 2018;10:9969–79.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

141.

Feng J, Xing M, Qian W, Qiu J, Liu X..
An injectable hydrogel combining medicine and matrix with anti-inflammatory and pro-angiogenic properties for potential treatment of myocardial infarction. Regen Biomater 2023;10:rbad036.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

142.

Zheng J, Song X, Yang Z, Yin C, Luo W, Yin C, Ni Y, Wang Y, Zhang Y..
Self-assembly hydrogels of therapeutic agents for local drug delivery. J Control Release 2022;350:898–921.

[
DOI
] [
PubMed
] [
Google Scholar
]

143.

Zhang H, Wu S, Chen W, Hu Y, Geng Z, Su J..
Bone/cartilage targeted hydrogel: strategies and applications. Bioact Mater 2023;23:156–69.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

144.

Grindy SC, Learsch R, Mozhdehi D, Cheng J, Barrett DG, Guan Z, Messersmith PB, Holten-Andersen N..
Control of hierarchical polymer mechanics with bioinspired metal-coordination dynamics. Nat Mater 2015;14:1210–6.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

145.

Shao T, Falcone N, Kraatz H-B..
Supramolecular peptide gels: influencing properties by metal ion coordination and their wide-ranging applications. ACS Omega 2020;5:1312–7.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

146.

Che QT, Charoensri K, Seo JW, Nguyen MH, Jang G, Bae H, Park HJ..
Triple-conjugated photo-/temperature-/pH-sensitive chitosan with an intelligent response for bioengineering applications. Carbohydr Polym 2022;298:120066.

[
DOI
] [
PubMed
] [
Google Scholar
]

147.

Jing H, Huang X, Du X, Mo L, Ma C, Wang H..
Facile synthesis of pH-responsive sodium alginate/carboxymethyl chitosan hydrogel beads promoted by hydrogen bond. Carbohydr Polym 2022;278:118993.

[
DOI
] [
PubMed
] [
Google Scholar
]

148.

Zhang X, Huang P, Jiang G, Zhang M, Yu F, Dong X, Wang L, Chen Y, Zhang W, Qi Y, Li W, Zeng H..
A novel magnesium ion-incorporating dual-crosslinked hydrogel to improve bone scaffold-mediated osteogenesis and angiogenesis. Mater Sci Eng C Mater Biol Appl 2021;121:111868.

[
DOI
] [
PubMed
] [
Google Scholar
]

149.

Zhao Z, Li G, Ruan H, Chen K, Cai Z, Lu G, Li R, Deng L, Cai M, Cui W..
Capturing magnesium ions via microfluidic hydrogel microspheres for promoting cancellous bone regeneration. ACS Nano 2021;15:13041–54.

[
DOI
] [
PubMed
] [
Google Scholar
]

150.

Cui T, Yu J, Wang C-F, Chen S, Li Q, Guo K, Qing R, Wang G, Ren J..
Micro-gel ensembles for accelerated healing of chronic wound via pH regulation. Adv Sci (Weinh) 2022;9:e2201254.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

151.

Wahid F, Zhong C, Wang H-S, Hu X-H, Chu L-Q..
Recent advances in antimicrobial hydrogels containing metal ions and metals/metal oxide nanoparticles. Polymers 2017;9:636.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

152.

Zhou H, Yu K, Jiang H, Deng R, Chu L, Cao Y, Zheng Y, Lu W, Deng Z, Liang B..
A three-in-one strategy: injectable biomimetic porous hydrogels for accelerating bone regeneration via shape-adaptable scaffolds, controllable magnesium ion release, and enhanced osteogenic differentiation. Biomacromolecules 2021;22:4552–68.

[
DOI
] [
PubMed
] [
Google Scholar
]

153.

Xing M, Jiang Y, Bi W, Gao L, Zhou Y-L, Rao S-L, Ma L-L, Zhang Z-W, Yang H-T, Chang J..
Strontium ions protect hearts against myocardial ischemia/reperfusion injury. Sci Adv 2021;7:eabe0726.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

154.

Zhang Y, Li X, Zhang Z, Li H, Chen D, Jiao Y, Fan C, Zeng Z, Chang J, Xu Y, Peng B, Yang C, Que Y..
Zn
2
SiO
4
bioceramic attenuates cardiac remodeling after myocardial infarction. Adv Healthc Mater 2023;12:e2203365.
[
DOI
] [
PubMed
] [
Google Scholar
]

155.

Lin Z, Fan D, Li G, He L, Qin X, Zhao B, Liang WQ, Antibacterial W..
Adhesive, and conductive hydrogel for diabetic wound healing. Macromol Biosci 2023;23:e2200349.
[
DOI
] [
PubMed
] [
Google Scholar
]

156.

Liu X, Zhou S, Cai B, Wang Y, Deng D, Wang X..
An injectable and self-healing hydrogel with antibacterial and angiogenic properties for diabetic wound healing. Biomater Sci 2022;10:3480–92.

[
DOI
] [
PubMed
] [
Google Scholar
]

157.

Long L, Hu C, Liu W, Wu C, Lu L, Li Y, Wang Y..
Injectable multifunctional hyaluronic acid/methylcellulose hydrogels for chronic wounds repairing. Carbohydr Polym 2022;289:119456.

[
DOI
] [
PubMed
] [
Google Scholar
]

158.

Wang G, Gao C, Xiao B, Zhang J, Jiang X, Wang Q, Guo J, Zhang D, Liu J, Xie Y, Shu C, Ding J..
Research and clinical translation of trilayer stent-graft of expanded polytetrafluoroethylene for interventional treatment of aortic dissection. Regen Biomater 2022;9:rbac049.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

159.

Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L..
Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987;316:701–6.

[
DOI
] [
PubMed
] [
Google Scholar
]

160.

Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachojannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW..
Long-term safety of drug-eluting and bare-metal stents evidence from a comprehensive network Meta-Analysis. J Am Coll Cardiol 2015;65:2496–507.

[
DOI
] [
PubMed
] [
Google Scholar
]

161.

Lu Y, Ren T, Zhang H, Jin Q, Shen L, Shan M, Zhao X, Chen Q, Dai H, Yao L, Xie J, Ye D, Lin T, Hong X, Deng K, Shen T, Pan J, Jia M, Ling J, Li P, Zhang Y, Wang H, Zhuang L, Gao C, Mao J, Zhu Y..
A honeybee stinger-inspired self-interlocking microneedle patch and its application in myocardial infarction treatment. Acta Biomater 2022;153:386–98.

[
DOI
] [
PubMed
] [
Google Scholar
]

162.

Zhao D, Yu K, Sun T, Jing X, Wan Y, Chen K, Gao H, Wang Y, Chen L, Guo X, Wei Q..
Material-structure-function integrated additive manufacturing of degradable metallic bone implants for load-bearing applications. Adv Funct Mater 2023;33.
[
Google Scholar
]

163.

Wang L, Pang Y, Tang Y, Wang X, Zhang D, Zhang X, Yu Y, Yang X, Cai Q..
A biomimetic piezoelectric scaffold with sustained Mg2+ release promotes neurogenic and angiogenic differentiation for enhanced bone regeneration. Bioact Mater 2023;25:399–414.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

164.

Zhang H, Ma W, Ma H, Qin C, Chen J, Wu C..
Spindle-like zinc silicate nanoparticles accelerating innervated and vascularized skin burn wound healing. Adv Healthc Mater 2022;11:e2102359.
[
DOI
] [
PubMed
] [
Google Scholar
]

165.

Gao P, Qiu H, Xiong K, Li X, Tu Q, Wang H, Lyu N, Chen X, Huang N, Yang Z..
Metal-catechol-(amine) networks for surface synergistic catalytic modification: therapeutic gas generation and biomolecule grafting. Biomaterials 2020;248:119981.

[
DOI
] [
PubMed
] [
Google Scholar
]

166.

Wang B, Hua J, You R, Yan K, Ma L..
Electrochemically deposition of catechol-chitosan hydrogel coating on coronary stent with robust copper ions immobilization capability and improved interfacial biological activity. Int J Biol Macromol 2021;181:435–43.

[
DOI
] [
PubMed
] [
Google Scholar
]

167.

Lih E, Kum CH, Park W, Chun SY, Cho Y, Joung YK, Park K-S, Hong YJ, Ahn DJ, Kim B-S, Kwon TG, Jeong MH, Hubbell JA, Han DK..
Modified magnesium hydroxide nanoparticles inhibit the inflammatory response to biodegradable poly(lactide- co-glycolide) implants. ACS Nano 2018;12:6917–25.

[
DOI
] [
PubMed
] [
Google Scholar
]

168.

Lin Y-H, Lee AK-X, Ho C-C, Fang M-J, Kuo T-Y, Shie M-Y..
The effects of a 3D-printed magnesium-/strontium-doped calcium silicate scaffold on regulation of bone regeneration via dual-stimulation of the AKT and WNT signaling pathways. Biomater Adv 2022;133:112660.

[
DOI
] [
PubMed
] [
Google Scholar
]

169.

Huang X, Huang D, Zhu T, Yu X, Xu K, Li H, Qu H, Zhou Z, Cheng K, Wen W, Ye Z..
Sustained zinc release in cooperation with CaP scaffold promoted bone regeneration via directing stem cell fate and triggering a pro-healing immune stimuli. J Nanobiotechnology 2021;19:207.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

170.

Li J, Zhao C, Liu C, Wang Z, Ling Z, Lin B, Tan B, Zhou L, Chen Y, Liu D, Zou X, Liu W..
Cobalt-doped bioceramic scaffolds fabricated by 3D printing show enhanced osteogenic and angiogenic properties for bone repair. Biomed Eng Online 2021;20:70.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

171.

Wu T, Li B, Huang W, Zeng X, Shi Y, Lin Z, Lin C, Xu W, Xia H, Zhang T..
Developing a novel calcium magnesium silicate/graphene oxide incorporated silk fibroin porous scaffold with enhanced osteogenesis, angiogenesis and inhibited osteoclastogenesis. Biomed Mater 2022;17:035012.
[
DOI
] [
PubMed
] [
Google Scholar
]

172.

Li Y, Chen M, Yan J, Zhou W, Gao S, Liu S, Li Q, Zheng Y, Cheng Y, Guo Q..
Tannic acid/Sr2+-coated silk/graphene oxide-based meniscus scaffold with anti-inflammatory and anti-ROS functions for cartilage protection and delaying osteoarthritis. Acta Biomater 2021;126:119–31.

[
DOI
] [
PubMed
] [
Google Scholar
]

173.

Zhang B, Qin Y, Yang L, Wu Y, Chen N, Li M, Li Y, Wan H, Fu D, Luo R, Yuan L, Wang Y..
A polyphenol-network-mediated coating modulates inflammation and vascular healing on vascular stents. ACS Nano 2022;16:6585–97.

[
DOI
] [
PubMed
] [
Google Scholar
]

174.

Hua J, Yang H, Wang B, Dai Y, Li X, Yan K, You R, Ma L..
Silk fibroin/chitosan coating with tunable catalytic nitric oxide generation for surface functionalization of cardiovascular stents. Int J Biol Macromol 2023;228:261–72.

[
DOI
] [
PubMed
] [
Google Scholar
]

175.

Yan J, Xia D, Zhou W, Li Y, Xiong P, Li Q, Wang P, Li M, Zheng Y, Cheng Y..
pH-responsive silk fibroin-based CuO/Ag micro/nano coating endows polyetheretherketone with synergistic antibacterial ability, osteogenesis, and angiogenesis. Acta Biomater 2020;115:220–34.

[
DOI
] [
PubMed
] [
Google Scholar
]

176.

Lu H-T, Huang G-Y, Chang W-J, Lu T-W, Huang T-W, Ho M-H, Mi F-L..
Modification of chitosan nanofibers with CuS and fucoidan for antibacterial and bone tissue engineering applications. Carbohydr Polym 2022;281:119035.

[
DOI
] [
PubMed
] [
Google Scholar
]

177.

Xie H, Xia H, Huang L, Zhong Z, Ye Q, Zhang L, Lu A..
Biocompatible, antibacterial and anti-inflammatory zinc ion cross-linked quaternized cellulose-sodium alginate composite sponges for accelerated wound healing. Int J Biol Macromol 2021;191:27–39.

[
DOI
] [
PubMed
] [
Google Scholar
]

178.

Yao S, Wang CJ, Zhao Y, Luo Y, Wang Y..
Y. Zn-MOF encapsulated antibacterial and degradable microneedles array for promoting wound healing. Adv Healthc Mater 2021;10:e2100056.
[
DOI
] [
PubMed
] [
Google Scholar
]

179.

Ying X, Qipu F, Lu H, Xia M, Pengfei H, Wenjing Z, Yujian JK..
Copper promotes cardiac functional recovery via suppressing the transformation of fibroblasts to myofibroblasts in ischemia-infarcted monkey hearts. J Nutr Biochem 2023;111:109180.

[
DOI
] [
PubMed
] [
Google Scholar
]

180.

Duan J, Chen Z, Liang X, Chen Y, Li H, Tian X, Zhang M, Wang X, Sun H, Kong D, Li Y, Yang J..
Construction and application of therapeutic metal-polyphenol capsule for peripheral artery disease. Biomaterials 2020;255:120199.

[
DOI
] [
PubMed
] [
Google Scholar
]

181.

Yu S, Sun T, Liu W, Yang L, Gong H, Chen X, Li J, Weng J..
PLGA cage-like structures loaded with Sr/Mg-doped hydroxyapatite for repairing osteoporotic bone defects. Macromol Biosci 2022;22:e2200092.
[
DOI
] [
PubMed
] [
Google Scholar
]

182.

Xiao J, Zhou Y, Ye M, An Y, Wang K, Wu Q, Song L, Zhang J, He H, Zhang Q, Wu J..
Freeze-thawing chitosan/ions hydrogel coated gauzes releasing multiple metal ions on demand for improved infected wound healing. Adv Healthc Mater 2021;10:e2001591.
[
DOI
] [
PubMed
] [
Google Scholar
]

183.

Ding X, Xie H, Kang J..
The significance of copper chelators in clinical and experimental application. J Nutr Biochem 2011;22:301–10.

[
DOI
] [
PubMed
] [
Google Scholar
]

184.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R..
Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 2021;20:101–24.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

185.

Selmani A, Kovacevic D, Bohinc K..
Nanoparticles: from synthesis to applications and beyond. Adv Colloid Interface Sci 2022;303:102640.

[
DOI
] [
PubMed
] [
Google Scholar
]

186.

Park W, Na K..
Advances in the synthesis and application of nanoparticles for drug delivery. Wires Nanomed Nanobi 2015;7:494–508.
[
DOI
] [
PubMed
] [
Google Scholar
]

187.

Yetisgin AA, Cetinel S, Zuvin M, Kosar A, Kutlu O..
Therapeutic nanoparticles and their targeted delivery applications. Molecules 2020;25:2193.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

188.

De Jong WH, Borm PJA..
Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 2008;3:133–49.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

189.

Catoira MC, Fusaro L, Di Francesco D, Ramella M, Boccafoschi F..
Overview of natural hydrogels for regenerative medicine applications. J Mater Sci Mater Med 2019;30:115.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

190.

Cao H, Duan L, Zhang Y, Cao J, Zhang K..
Current hydrogel advances in physicochemical and biological response-driven biomedical application diversity. Signal Transduct Target Ther 2021;6:426.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

191.

Zhu H, Zheng J, Oh XY, Chan CY, Low BQL, Tor JQ, Jiang W, Ye E, Loh XJ, Li Z..
Nanoarchitecture-integrated hydrogel systems toward therapeutic applications. ACS Nano 2023;17:7953–78.

[
DOI
] [
PubMed
] [
Google Scholar
]

192.

Nambiar J, Jana S, Nandi SK..
Strategies for enhancing vascularization of biomaterial-based scaffold in bone regeneration. Chem Rec 2022;22:e202200008.
[
DOI
] [
PubMed
] [
Google Scholar
]

193.

Sarkhosh-Inanlou R, Shafiei-Irannejad V, Azizi S, Jouyban A, Dolatabadi JE-N, Mobed A, Adel B, Soleymani J, Hamblin MR..
Applications of scaffold-based advanced materials in biomedical sensing. Trends Analyt Chem 2021;143:116342.
[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

194.

Tian GE, Ren TC..
Mechanical stress regulates the mechanotransduction and metabolism of cardiac fibroblasts in fibrotic cardiac diseases. Eur J Cell Biol 2023;102:151288.

[
DOI
] [
PubMed
] [
Google Scholar
]

195.

Zhang X, Chen X, Hong H, Hu R, Liu J, Liu C..
Decellularized extracellular matrix scaffolds: recent trends and emerging strategies in tissue engineering. Bioact Mater 2022;10:15–31.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

196.

Woods KL, Fletcher S, Roffe C, Haider Y..
Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553–8.

[
DOI
] [
PubMed
] [
Google Scholar
]

197.

Roth A, Eschar Y, Keren G, Kerbel S, Harsat A, Villa Y, Laniado S, Miler HI..
Effect of magnesium on restenosis after percutaneous transluminal coronary angioplasty: a clinical and angiographic evaluation in a randomized patient population. A pilot study. The Ichilov Magnesium Study Group. Eur Heart J 1994;15:1164–73.

[
DOI
] [
PubMed
] [
Google Scholar
]

198.

Hekkelman ML, de Vries I, Joosten RP, Perrakis A..
AlphaFill: enriching AlphaFold models with ligands and cofactors. Nat Methods 2023;20:205.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

199.

Joy DA, Libby ARG, McDevitt TC..
Deep neural net tracking of human pluripotent stem cells reveals intrinsic behaviors directing morphogenesis. Stem Cell Reports 2021;16:1317–30.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

200.

Zhang X-P, Lin B, Shu Y, Wang J-H..
“Switch-on” fluorescence sensing platform based on porphyrin metal-organic frameworks for rapid and specific detection of zinc ion. Anal Bioanal Chem 2021;413:5161–8.

[
DOI
] [
PubMed
] [
Google Scholar
]

201.

Zhao Y, Zhang W, Van Devener B, Bunch TD, Zhou A, Isom SC..
In-situ characterization of porcine fibroblasts in response to silver ions by Raman spectroscopy and liquid scanning transmission electron microscopy. Talanta 2022;246:123522.

[
DOI
] [
PubMed
] [
Google Scholar
]

202.

Yang S-C, Welter L, Kolatkar A, Nieva J, Waitman KR, Huang K-F, Liao W-H, Takano S, Berelson WM, West AJ, Kuhn P, John SG..
A new anion exchange purification method for Cu stable isotopes in blood samples. Anal Bioanal Chem 2019;411:765–76.

[
DOI
] [
PMC free article
] [
PubMed
] [
Google Scholar
]

Articles from Regenerative Biomaterials are provided here courtesy of
Oxford University Press

ACTIONS

View on publisher site

PDF (1.8 MB)

Cite

Collections

Permalink

PERMALINK

Copy

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

Cite

Copy

Download .nbib

.nbib

Format:

AMA

APA

MLA

NLM

Add to Collections

Create a new collection

Add to an existing collection

Name your collection

*

Choose a collection

Unable to load your collection due to an error

Please try again

Add

Cancel

Follow NCBI

NCBI on X (formerly known as Twitter)

NCBI on Facebook

NCBI on LinkedIn

NCBI on GitHub

NCBI RSS feed

Connect with NLM

NLM on X (formerly known as Twitter)

NLM on Facebook

NLM on YouTube

National Library of Medicine

8600 Rockville Pike
Bethesda, MD 20894

Web Policies

FOIA

HHS Vulnerability Disclosure

Help

Accessibility

Careers

NLM

NIH

HHS

USA.gov

Back to Top
</reference>

<statements>
1. Epidemiologic and mechanistic studies suggest that dysregulated plasma or serum levels of several metals are associated with increased risks of coronary heart disease (CHD), stroke, arrhythmias, and cardiovascular mortality, raising the question of whether intentional modulation (e.g., supplementation or chelation) could be preventive or therapeutic.
2. A recent review synthesized preclinical and translational data on exogenous metal ions as therapeutic agents in CVD, outlining three main beneficial mechanisms: protection from oxidative stress, induction of angiogenesis, and modulation of ion channel function.
3. Metals such as zinc and selenium participate in antioxidant defense systems (e.g., zinc-dependent enzymes, selenoproteins like glutathione peroxidases). Supplementation in deficient states can reduce lipid peroxidation and attenuate oxidative injury to vascular and myocardial tissues, potentially slowing atherosclerosis progression.
4. Certain metal ions (e.g., copper, cobalt) can stimulate angiogenic pathways and may support collateral vessel formation in ischemic tissues, though the same pro-angiogenic properties can be oncogenic or pro-atherogenic at inappropriate doses.
5. Magnesium and calcium are central to myocardial excitability and conduction, and acute modulation of magnesium levels is known to affect arrhythmia susceptibility and vascular tone.
6. A randomized, double-blind controlled study of 2,316 patients with suspected acute MI found that intravenous magnesium sulfate significantly reduced early mortality and left ventricular failure compared with placebo. These benefits are thought to derive from magnesium’s anti-arrhythmic, vasodilatory, and cytoprotective effects at pharmacologic concentrations, though subsequent trials and meta-analyses have yielded mixed results and the routine use of IV magnesium in acute MI is not universally adopted.
7. Clinical studies have also reported a trend toward reduced restenosis rates after percutaneous coronary angioplasty in patients receiving magnesium, suggesting possible protective effects on vascular healing, but data are limited and not definitive.
8. Zinc participates in numerous enzymatic and transcriptional processes and has antioxidant properties, making it a candidate for atheroprotection.
9. In elderly subjects with low baseline plasma zinc, zinc supplementation increased plasma zinc levels and significantly reduced plasma lipid peroxidation indices, suggesting a reduction in oxidative stress that may, in theory, prevent atherosclerosis.
10. Selenium is integral to selenoproteins involved in antioxidant defense and thyroid function.
11. The idea of delivering metal ions locally—for example via stents, scaffolds, or nanocarriers—to harness their angiogenic or anti-inflammatory properties while minimizing systemic exposure is conceptually appealing.
12. Preclinical studies have explored metal-doped biomaterials (e.g., magnesium-based stents that biodegrade and release magnesium ions; copper-containing scaffolds that promote angiogenesis), but clinical trials explicitly designed to assess cardiovascular outcomes of such localized metal ion delivery remain scarce.
13. A recent review noted that current clinical research predominantly focuses on systemic cyclic drug administration that incidentally alters metal ion concentrations, rather than targeted local metal ion therapies.
14. IV magnesium sulfate is standard in certain acute care settings and can be delivered safely under monitoring, making it feasible for acute interventions (e.g., MI, arrhythmias). Trial data support short-term reductions in specific endpoints, but long-term benefits are less clear.
15. Zinc and selenium are promising in specific contexts, particularly where deficiency is present, and may reduce oxidative stress or improve certain risk factors, but evidence for event reduction is limited and potential risks at high exposures require caution.
16. Future research should emphasize targeted local delivery approaches that exploit beneficial metal ion effects while minimizing systemic toxicity.
</statements>

Begin the assessment now. Output only the JSON list, without any conversational text or explanations.